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ABSTRACT 
COMPUTATIONAL STUDIES ON R67 DIHYDROFOLATE REDUCTASE: 
AN INVESTIGATION INTO ITS UNIQUE BINDING PATTERNS 
Chuanyin Shi 
Old Dominion University, 2009 
Director: Dr. Jennifer L. Poutsma 
R67 dihydrofolate reductase (R67 DHFR) is a plasmid encoded enzyme which 
catalyzes the reduction of dihydrofolate (DHF) to tetrahydrofolate (THF) using NADPH 
as a cofactor. R67 DHFR is a homo-tetramer and D2 symmetric. It contains only one 
active site, which spans the central channel of the enzyme. The active site can bind either 
two reactants (DHF), two cofactors (NADPH) or one of each (NADPH/DHF), which is 
the productive ternary complex (i.e. the complex which yields product). In order to favor 
formation of the productive complex, this enzyme exhibits binding cooperativity. Unlike 
other allosteric enzymes which achieve binding cooperativity through conformational 
changes, this enzyme does not appear to undergo any backbone alterations upon ligand 
binding. Therefore, a different mechanism must be involved in the cooperativity. In this 
study, computational approaches were employed to better understand the source of the 
unique binding patterns of this enzyme. 
Molecular dynamics simulations were initially performed on complexes involving 
truncated ligands and then the full ligands and mutants were studied. Agreement was 
found between the simulated results and experimental data. A well-maintained backbone 
conformation was observed for all simulated complexes and the calculated binding 
energies were able to reproduce the cooperative binding patterns for the truncated and full 
ligand studies. Residue Q67 can fold down to create additional room for the ligands in the 
active site while Y69 can fortify the H-bonding network to NADPH. The largest 
contribution to the binding cooperativity came from ligand-ligand interactions and 
electrostatic interactions. The DHF tail is extremely flexible and accounts for the lower 
binding energy of DHF. In addition, the ring area of DHF was also found to be flexible 
and adopted different binding positions. Losing the interaction to residue K32 
significantly reduced DHF's binding energy while this effect is less profound for NADPH. 
Simulations on the mutants suggest that the NADPH binding conformation did not 
undergo any significant changes. The correct binding site for a single DHF ligand 
remains unclear as the results were unable to reproduce the tighter binding to the mutant. 
dedicated to my mother and father 
who always supported me 
VI 
ACKNOWLEDGMENTS 
Of all the people who helped or encouraged me during my graduate career, I am 
most thankful to Dr. Jennifer L. Poutsma, who led me into the computational field. I am 
always grateful to her for her continuous support, detailed guidance, and good working 
environment. My committee members: Dr. Kenneth Brown, Dr. Patricia Pleban, Dr. Colm 
Whelan, and Dr. Nancy Xu were always helpful and responsible. I thank them for their 
cooperation through the many events in my graduate study. 
Jeff Tibbitt and Jessica Gleason were involved in the system setup and part of the 
dynamics simulations. I especially want to thank Jeff for his great help in solving many 
of the encountered problems. I am thankful to Dr. Howell for providing the docked 
structures and the latest crystal structures. Dr. Zoete and Dr. Karplus provided the 
protocol of per-residue free energy decomposition. Special thanks are given to Dr. Lesley 
Greene and Dr. Paula Mazzer who helped in reviewing the dissertation and the 
manuscript for journal submission. 
During my teaching career, I always got help and assistance from Alicia Herr and 
Tammy Subotich. I would like to thank them for their patience, as I bothered them 
heavily. I need to thank Janice Moore helping me with my room reservation and making 
my defense happen in time. I am always had a good time during my graduate study, 
thanks to my coworkers Anna Manukyan and Sonia Antony, who are a source of 
happiness and relaxation in the office. I appreciate Sonia's help for preparing some of my 
paperwork and finalizing my dissertation. 
I am grateful to NIH for funding and NCSA, Pittsburgh supercomputing center, 
and Old Dominion University for computing time. I especially want to thank ODU for 
the new cluster "go-zorka". This dissertation would not be finished without the 
computing power and reliability of it. It really deserves its name and makes my work on 
the go. 
vii 
TABLE OF CONTENTS 
Page 
LIST OF TABLES ix 
LIST OF FIGURES x 
Chapter 
I. INTRODUCTION 1 
Dihydrofolate Reductase 1 
Ligand Binding Cooperativity 5 
Ligand Binding Conformations 6 
Hydride Transfer 9 
Factors Involved in Ligand Binding 10 
Experimental Mutational Studies 12 
II. METHODOLOGY 18 
Computational Chemistry 18 
Quantum Mechanics and Molecular Mechanics 18 
CHARMM Force Fields 20 
Molecular Dynamics Simulation 26 
Conformational Analyses 32 
Ligand Binding Free Energy 34 
Electrostatic Potential 39 
III. TRUNCATED LIGAND STUDY. 40 
Introduction 40 
Methods 41 
Results and Discussion 42 
Conclusions 69 
IV. FULL LIGAND STUDY 71 
Introduction 71 
Results and Discussion 73 
Conclusions 100 
viii 
V. MUTATIONAL STUDY 102 
Introduction 102 
Results and Discussion 104 
Conclusions 120 
VI. SUMMARY 123 
REFERENCES 125 
APPENDIXES 
A. Abbreviations 132 
B. Supplemental Figures 134 
VITA 137 
ix 
LIST OF TABLES 
Table Page 
1. Dis sociation constants for the asymmetric Q67H mutational study 15 
2. The simulated complexes involving truncated ligands 41 
3. RMSDs between the average structures and X-ray crystal structure 48 
4. Binding energies of the simulated complexes involving truncated ligands 50 
5. Residue contacts between the protein and truncated ligands 55 
6. The simulated complexes involving full ligands 73 
7. Binding energies of the simulated complexes involving full ligands 83 
8. Residue contacts between the protein and full ligands 89 
9. Hydrogen bonds between the protein and the ligands 90 
10. Residue contributions to the NADPH binding free energy 93 
11. Backbone contributions to the NADPH binding free energy 94 
12. Side-chain contributions to the NADPH binding free energy 94 
13. Residue contributions to the DHF binding free energy 97 
14. Backbone contributions to the DHF binding free energy 98 
15. Side-chain contributions to the DHF binding free energy 99 
16. The simulated mutants involving full ligands 103 
17. Binding energies of the simulated mutants 110 
18. Hydrogen bonds between the mutated protein and the ligands 119 
X 
LIST OF FIGURES 
Figure Page 
1. Schematic representation of the DHFR catalyzed reaction 2 
2. X-ray crystal structures of E. Coli chromosomal DHFR and R67 DHFR 3 
3. The binding scheme and related dissociation constants (K^) of R67 DHFR 6 
4. The endo and exo transition states for the DHFR reaction 9 
5. A schematic diagram of the terms in the potential energy function 22 
6. Diagram of Urey-Bradley interaction and van der Waals interaction 24 
7. The solvation and periodic boundary condition of dynamics simulation 29 
8. The diagram of a thermodynamic cycle 35 
9. Backbone RMSDs and radius of gyration of simulated complexes 42 
10. Ligand RMSDs for selected complexes containing the PTE ligand(s) 43 
11. Ligand conformations from the average structures 44 
12. Hydride transfer distances between PTE (C6) and NR (NH4) 46 
13. Backbone overlap of the X-ray crystal structure and simulated complexes 47 
14. Conformations of the key residues in the average structures 56 
15. Hydrogen bonding networks in R67/NR/NR and R67/NR/tDHF 59 
16. Contacts between protein-ligand or ligand-ligand 61 
17. Electrostatic potential surfaces of the ligands and simulated complexes 62 
18. RMS fluctuations of the simulated complexes 65 
xi 
19. Changes in RMS fluctuations upon binding of a second tDHF 66 
20. Covariance matrices for the R67 DHFR complexes 67 
21. Trajectory RMSDs between selected complexes 69 
22. The four major conformations of the DHFligands 72 
23. Backbone RMSDs vs. time for the simulated complexes 74 
24. LigandRMSD plots of the simulated complexes 75 
25. Overlap of the average structures containing NADPH 77 
26. Overlap of the average structures containing DHF 78 
27. Overlap of the average structures containing DHF/DHF 80 
28. The starting and average structure of R67/NR:A and R67/NR/NR:A 105 
29. Overlap of the average structures containing NADPH 106 
30. The average structures of R67/NX: A and R67/NX/NX: A 108 
31. The syn and anti conformations of NADPH Il l 
32. The average structures of R67/NADPH/NADPH two-site mutants 113 
33. The average structures of R67/NADPH/DHF single-site mutants 115 
34. The average structures of R67/DHF/DHF single-site mutants 118 
35. Structures of truncated ligands (tFOL, tDHF, tDHFH+, and NR) 133 
36. Backbone overlap of the X-ray crystal structure and simulated complexes 133 
37. Backbone overlap of the X-ray crystal structure and simulated complexes 134 
38. Backbone RMSDs vs. time for the simulated complexes 134 
xii 




1.1 Dihydrofolate Reductase 
Dihydrofolate reductase (DHFR) is a ubiquitous enzyme found in all organisms.1 
It catalyzes the reduction of 7, 8-dihydrofolate (DHF) to 5, 6, 7, 8-tetrahydrofolate (THF) 
by hydride transfer from the nicotinamide adenine dinucleotide phosphate (NADPH) 
cofactor to the C6 atom on the pteridine (PTE) ring on DHF (Fig. 1). During the reaction, 
the cofactor is converted into its oxidized form (NADP+). This reaction is crucial in folate 
metabolism since THF is a one-carbon donor in the synthesis of thymidylate, purine 
nucleosides, and other metabolic intermediates. DHFR is the only source for maintaining 
the cellular THF level. Therefore, inhibition of this enzyme leads to blockage of DNA 
synthesis and eventually cell death. DHFR is also able to carry out the reduction of 
folate to DHF but at a much lower rate. 
Folate analogues (antifolates) can selectively inhibit DHFR in different species. 
The selective inhibition feature and the important metabolic role makes DHFR a prime 
target for antifolate drug research in the treatment of cancer as well as bacterial and 
parasitic infections.3'4 Hitchings and collaborators developed pyrimethamine (1950) and 
trimethoprim (TMP, 1956) which were found to be effective in the treatment of malara 
and bacterial infections. Pyrimethamine is 2,000 times more toxic to the enzyme system 
in the malaria parasite than in the host. In particular, the drug trimethoprim (TMP) is 
effective in the treatment of malaria and bacterial infections because of its strong affinity 
to the DHFR. TMP has a 100,000 times stronger affinity for the bacterial enzyme than for 
the human enzyme. Bacterial resistance to TMP was first reported in 1972 by Fleming et 
al. and was found to be correlated with resistant plasmids (R-plasmids).5'6 
This dissertation is formatted according to the Journal of Molecular Biology. 
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Fig. 1. Schematic representation of the DHFR catalyzed reaction. The pteridine ring 
(PTE) and nicotinamide-ribose ring (ribonicotinamide, NR) refer to the ring areas of the 
substrate and the cofactor. The 4'-aminobenzoylglutamate (pABA-GLU) and the 
pyrophosphate along with adenosine are considered as the tail moiety for these two 
ligands. The DHF has a total charge of -2 which is located on the tail and NADPH has a 
total charge of -4 spread on the pyrophosphate bridge and adenosine tail. 
Plasmid-encoded DHFRs are currently classified into two major families (dfrA 
and dfrB) with 17 different types (I-XVII).7 The sequences in the dfrA family (Type I, 
III-XVII) are closely related to the bacterial chromosomal DHFRs and the key residues 
involved in ligand binding are also conserved.8 The type II enzyme, which belongs to the 
dfrB family, was discovered and isolated in the mid 1970s.6 This enzyme is encoded by 
the R67 plasmid and thus is also called R67 DHFR. It is 1,000 fold less sensitive to TMP 
and thus confers drug resistance. Unlike most plasmid enzymes which show sequence or 
structural homology with their chromosomal counterparts, this enzyme has no sequence 
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or structural relationship to chromosomal DHFR and yet carries out the same reaction 
(Fig. 2).7'9 
The chromosomal DHFR is a monomer consisting of two rigid subdomains 
separated by a hinge region (Fig 2a).10 The most widely studied chromosomal DHFR is 
from E. coli. This enzyme has an active site volume of 1,677 A3. It uses the movement of 
a floppy loop (M20 loop) as well as subdomain rotation to minimize the access of solvent 
to the active site as well as modulating ligand specificity. This enzyme is considered a 
well evolved enzyme with a high KCSA value of 29 s"
1 and product release as the rate 
limiting step.11'12 
Fig. 2. X-ray crystal structure of E. Coli chromosomal DHFR and R67 DHFR. a) E. 
Coli chromosomal DHFR with NADPH (red) and DHF (green) ligands. b) The 
homo-tetrameric R67 DHFR. Monomers A, B, C, D are shown in red, yellow, green and 
blue ribbons respectively. The residues are numbered as 1-78, 101-178, 201-278, and 
301-378 on each monomer. Current image only shows residues 19-78 and repeated 
counterparts as resolved by X-ray crystal study. The residue Q67s (Q67, Q167, etc.) in 
the center of the active site is displayed in orange while other important residues and the 
ligands are not displayed for clarity. 
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R67 DHFR is a homo-tetramer consisting of four identical 78 amino acid 
monomers and has a molecular weight of 34,000 Da. This enzyme is one of the smallest 
proteins known to assemble into an active tetrameric enzyme.13 R67 DHFR has a much 
lower #cat value of 1.3 s'than the chromosomal DHFR and the rate-determining step in 
R67 DHFR catalysis is hydride transfer.1415 At low pH, native R67 DHFR will dissociate 
to form inactive but stable dimers.16 Earlier X-ray crystallographic studies on the dimeric 
form of R67 DHFR indicates that the first 16 amino acids are disordered.17 Also, cleavage 
of the first 16 N-terminal residues of tetrameric R67 DHFR showed that the truncated 
protein is fully active with Kcat =1.3 s"
1, suggesting that the functional core of the protein 
resides in the P-barrel structure defined by residues 17-78.14 Therefore, in the later X-ray 
crystal studies of tetrameric R67 DHFR, chymotrypsin was used to selectively cleave the 
full-length protein at Phel6. This yielded a shortened fully active tetramer where each 
monomer contains 62 amino acids.14 Although the 16 N-terminal residues are not 
involved in catalysis, their presence is essential for the folding process because the gene 
coded for truncated R67 DHFR does not produce protein in vivo or confer TMP 
resistance.14 
The X-ray crystal structure of R67 DHFR showed that each monomer of the 
protein is composed of five anti parallel P-strands.17'18 The monomers assemble into 
dimers by forming a six-stranded p-barrel using three p-strands from each monomer. 
These dimers then form the tetramer through loop-loop contacts. During assembly, each 
monomer only uses 1,066 A (27%) from its total solvent accessible surface to form the 
intersubunit contacts which is much less compared to other oligomeric proteins.18 Among 
that, half of this area (535 A2) is contributed to the monomer-monomer interface (A/B or 
C/D) and the other half (531 A2) constructs the dimer-dimer interface (A/C or B/D). The 
contact surface in the R67 DHFR dimer is the smallest among all stable dimeric 
molecules yet reported.19 In the dimer-dimer interface, His62 is the only H-bond acceptor 
in the vicinity of the buried hydroxyl of Ser259. Therefore, at low pH, R67 DHFR will 
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dissociate into stable dimmers because protonation of His62 prevents an H-bond 
interaction with Ser259 and creates a positive charge in the buried dimer-dimer interface, 
which is unstable. 'l 
The resulting enzyme is D2 symmetric and doughnut shaped.18 It contains only 
one active site pore, which spans the central channel of the enzyme. This active site has a 
larger volume (3,626 A ) than was observed for the chromosomal DHFRs. In addition, 
the 222 symmetry (i.e. 2-fold rotational symmetry along x, y, and z axis) within the active 
pore creates four symmetry-related binding sites, which must be able to bind both DHF 
and NADPH. Also the tetramer structure makes it more vulnerable to genetic changes 
because one gene mutation will result in four mutations in the enzyme. These 
characteristics indicate that R67 DHFR is a primitive enzyme and less efficient than the 
chromosomal DHFR. 
1.2 Ligand Binding Cooperativity 
Although the active site possesses 222 symmetry, it is unlikely to bind four 
ligands due to steric constraints. Binding studies by time-resolved fluorescence 
anisotropy and isothermal titration calorimetry (ITC) indicate a maximum of two ligands 
can bind inside the active site. The possible combinations are DHF/DHF (or 
folate/folate), NADPH/NADPH, or NADPH/DHF (or NADPH/folate).20 The first two 
complexes are nonproductive, while the last one yields the product. Binding of the first 
NADPH is strong since it has a low dissociation constant (Ka), while binding of the 
second NADPH is weak as indicated by a higher Ka value (Fig. 3). This reduced binding 
(negative binding cooperativity) for the second NADPH suggests that the first NADPH 
binds at or near the center and impedes binding of a second NADPH at a 
symmetry-related site. The formation of the DHF/DHF (or folate/folate) or NADPH/DHF 
(or NADPH/folate) shows positive cooperativity, indicating that inter-ligand interactions 
may be involved in up-regulating the affinity of the second ligand. 
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Because of the positive and negative binding cooperativities, the enzyme 
establishes a preferred catalytic pathway where it binds the cofactor (NADPH) first and 
then the substrate (DHF), yielding the productive ternary complex.2 Presumably, NADPH, 
which has a much lower K& than DHF, binds first. Once bound, the R67/NADPH 
complex is not favored for the binding of a second NADPH while favors the binding of 
DHF, which is represented by the negative/positive binding cooperativities. This 
well-designed catalytic pathway indicates that "pre-organization" may be involved in 
binding the first ligand since the symmetry inside the active site is lost after the first 
ligand is bound.8 After the catalysis, the NADP+ likely leaves first because of its higher 
dissociation constant (~29 uM) followed by THF, which has a lower K& (-4.8 uM). 
. . Is 
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Fig. 3. The binding scheme and related dissociation constants (K£) of R67 DHFR. The 
preferred binding pathway is shown in green. 
1.3 Ligand Binding Conformations 
Although the productive ternary complex contains NADPH and DHF ligands, 
folate was used in the early conformational studies of this enzyme. In the X-ray crystal 
structure of R67 DHFR with folate bound (PDB ID: 1VIF), two alternative 
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conformations of the pteridine ring of folate were observed. From the fitting of the 
electron density, Fol I (the first folate conformation) was found to bind with its si face 
exposed, which is conductive to hydride transfer, whereas Fol II (the second folate 
conformation) has its si face nestled against the side of the pore, making it unavailable to 
accept a hydride transfer. Density for the p-aminobenzoyl acid-Glu (pABA-Glu) tail was 
not observed, indicating its disorder. The crystal structure and NMR studies indicate that 
the ring areas of DHF/DHF (or folate/folate) molecules overlap with each other near the 
center of the pore. ' Docking studies and inter-ligand NOEs also show stacking 
between the ring areas of folate and NADP+. The ring stacking was also found in the later 
crystallography studies for R67/NADP+/DHF.22 This structural tightness displays a 
positive correlation with the enthalpy of binding, and the enthalpy associated with 
addition of folate to wild type and mutant D67/NADPH complexes shows a potential 
linear correlation with catalytic efficiency. Therefore, the inter-ligand interactions play an 
important role in binding as well as catalysis. 
Obtaining the crystal or NMR structure of the ternary complex has proven 
especially difficult, as the fourfold symmetry within the pore results in a fourfold dilution 
of the signal. This difficulty, combined with the possibility of binding either folate or 
NADPH in each site further reduces the signal. Therefore, in a earlier study, a 
computational approach was used by Howell et. al. to model the productive ternary 
complex R67/DHF/NADPH. The bound pteridine ring of Fol I from the crystal structure 
was used to dock the nicotinamide-ribose-Pi (NMNH) moiety of NADPH. NMNH was 
positioned by two different algorithms (DOCK and SLIDE) on the opposite side of the 
pore from Fol I. Both approaches yielded similar results, where the NMNH interacts and 
stacks with Fol I at the pore's center.23'24 Docking studies and inter-ligand Nuclear 
Overhauser Effects (NOEs) show that the NADP+/folate complex also appears to involve 
stacking between the nicotinamide and pteridine rings. Therefore, ring stacking might be 
strongly correlated with the positive cooperativity associated with DHF/DHF (or 
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folate/folate) and NADPH/folate complex formation. 
To obtain further information on the positioning of the pABA-glu tail of folate, 
which is disordered in the crystal structure, Fol I was removed from the top-scoring R67 
DHFR Fol I/NMNH ternary complex and the full-length folate molecule docked. 
Although several constraints obtained from experimental data were used to eliminate 
unlikely binding modes, the pteridine ring of the folate was docked in the same general 
position as Fol I and the pABA-Glu tail of folate was found to have multiple reasonable 
conformations.21 Similar multiple tail conformations were also observed in Alonso et 
al.'s docking (AutoDock and FlexX) and dynamics simulation studies on the 
R67/NADPH/DHF ternary complexes. The simulation showed that the rings of the 
ligands exhibited deviations comparable with those of the protein backbone, but the 
movements of the tail regions, which are situated close to the openings of the active-site 
cavity had much higher fluctuations.25 Recent high resolution X-ray crystal structures 
(PDB ID: 2RK1) are able to predict the full length of NADPH, but the tail conformation 
of DHF still remains unresolved.22 
NMR studies reveal that NADP+ binds to R67 DHFR with a syn conformation 
between the nicotinamide ring and its ribose (i.e., the carboxamide group from the 
nicotinamide and the ribose ring oxygen atom are close.).21'2 The X-ray crystal structures 
containing NADP+ (PDB ID: 2RK1, 2RK2) also show the syn conformation.22 When the 
DHF ligand is added to NADPH, there are two possible conformations {endo and exo) for 
the transition state (Fig. 4).27 Due to structural constraints, the E.Coli DHFR adopts an 
exo transition state during catalysis and there is minimal overlap between the 
nicotinamide and pteridine rings.28 In contrast, the R67 DHFR uses an endo transition 
state as indicated by inter-ligand NOE data and docking studies of the ternary complex 
model. ' The shape and small size of the active site pore indicates that having both 
ligands lined up in the same direction will cause strong steric interactions upon binding, 
thus preventing formation of the exo transition state. The quantum-mechanical 
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calculations predict that the endo transition state is 2-8 kcal/mol more stable than the exo 
conformation due to the inter-ligand ring stacking effects.27'28. The X-ray crystal structure 
of the R67 DHFR ternary complex R67/NADP+/DHF (PDB ID: 2RK1) confirmed that 
the endo transition state is employed by this type II enzyme (Fig. 4).22 
^ T - * T * NADPH 
exo 
Fig. 4. The endo and exo transition states for the DHFR reaction. The endo 
conformation has both NADPH (red) and DHF (green) ligands head (ring) and tail lined 
up in the opposite direction while the exo conformation has the ring and tail lined up 
along the same direction. 
1.4 Hydride Transfer 
Unlike the chromosomal DHFRs which have conserved carboxyl groups for 
protonating DHF at the N5 atom prior to hydride transfer,29 the R67 DHFR active site has 
no side chains capable of general acid catalysis.18 This limitation originates from the 
symmetry of R67 DHFR, because the addition of a single acid catalysis site for 
protonating DHF would result in three more symmetrical changes on the protein and that 
many negative charges would most likely impede the binding of NADPH.8 Mutational 
studies on H62C R67 DHFR showed increased activity as the pH was lowered and this 
result is consistent with the use of protonated DHF (DHFH+) as the productive 
substrate.15 Also, the Raman difference measurements showed no indication of bound 
DHFH+ at pH 5.3.30 The active site is large and accessible to solvent, and the X-ray 
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structure (PDB ID: 1VIE) showed that the carbonyl oxygen of residue V66 is able to hold 
a water molecule within hydrogen-bonding distance of the N5 atom.18 These results 
suggest that water is responsible for the protonation of the N5 position. 
The hydrogen added to the C6 position of DHF comes from the cofactor, NADPH 
(C4 position), via hydride transfer. In the X-ray crystal structures of chromosomal 
DHFRs (PDB ID: 1DR1, 1RA2, 1RB2, 1RX2, and 7DFR), the hydride transfer distance 
between C4 of NADPH and C6 of DHF ranges from 3.30 to 3.56 A. A similar value (3.31 
A) is observed for the R67 DHFR ternary X-ray crystal structure (PDB ID: 2RK1).22 
However, docking studies predicted a different hydride transfer distance (C4-C6) for 
chromosomal DHFR than for R67 DHFR. Modeling of the NADPH/DHF ternary 
complex for the E. Coli chromosomal DHFR resulted in a shorter distance of 2.6 A,31 
which is the distance in the hydride transfer transition state calculated by using ab initio 
methods.32 In the docking studies of R67 DHFR, the R67/pteridine/NMN model predicts 
a distance (C4-C6) range of 4.06 to 4.30 A and the R67/DHF/NMN has C4-C6 distances 
ranging from 4.45 to 6.07 A.13. These distances are longer (> 1.4 A) than the ones 
predicted for the chromosomal DHFR and the distance in the ternary X-ray crystal 
structure (PDB ID: 2RK1). The greater hydride transfer distances observed in the R67 
DHFR from docking studies indicates that this enzyme will require a longer time to reach 
the necessary hydride transfer distance and have a lower rate of catalysis. Also, an 
inter-ligand chemical attraction may be important in shortening the distance between the 
two ligands. The predicted distance for R67/pteridine/NMN is shorter than for 
R67/DHF/NMN, suggesting the truncated ligand (pteridine) is easier to move inside the 
active site without the interference of the ligand tail. 
1.5 Factors Involved in Ligand Binding 
Unlike most enzymes that use conformational changes to achieve binding 
cooperativity, measurements of the dynamic behavior of R67 DHFR shows a well 
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maintained structure and minimal backbone motion. The X-ray crystal studies display 
similar backbone structures for all complexes studied. In addition, monitoring of the 
internal motions via order parameters, <S >, showed minimal alterations in dynamics 
upon ligand binding. The order parameter can vary between 1 (no internal motion) and 0 
(maximum internal motion). Addition of NADP+ to R67 DHFR did not result in any large 
change in the overall motion of the protein, as <S > is similar for the apo-enzyme (0.89) 
and the bound state (0.86); indicating cofactor binding caused no change in the protein 
dynamics.1 
Because of the rigid backbone, small active site size and symmetry of the active 
site, numerous residues most likely serve dual roles in ligand binding. For example, the 
Q67 residues from monomers B and D have contacts with the pteridine ring, while the 
Q67s from monomers A and C have contacts with the nicotinamide ring. In addition, 
residues 168 and Y69 are also involved in binding both ligands. These residues are 
generally amphipathic, thus both hydrophobic and hydrophilic contacts can be 
iyy -y A 
employed. ' The result is a "hot spot" binding surface that allows the same residues to 
co-optimize the binding of the two ligands, and orient them for catalysis.13 
While the protein backbone may just act as a scaffold for ligand binding, the 
electrostatic potential analyses showed that electrostatic interactions play an important 
role in R67 DHFR ligand binding. Interestingly, numerous enzymes utilize electrostatic 
potentials to guide ligands into the active site where specific interactions to the substrate 
can occur.34"36 The electrostatic potential, calculated by solving a nonlinear 
Poisson-Boltzmann equation, predicts a positively charged active site pore caused by the 
K32 and K33 residues located near the edge of the pore13. This positive potential should 
be attractive to the two negatively charged ligands, since NADPH has a net charge of -4, 
while folate/DHF has a net charge of -2 . Thus, the negative charge on the outside of the 
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torus may aid in electrostatic guidance But whether the electrostatic potential could also 
play an important role in binding cooperativity is still not clear. 
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Salt effects on NADPH binding uncovered two ionic interactions between R67 
DHFR and its ligands.37 When R67 DHFR's steady-state kinetic behavior was probed by 
increasing salt concentrations, at least one ionic interaction was identified in the binding 
of NADPH. An unusual enhancement of kcat caused by increased salt concentrations is 
consistent with the breaking of a salt bridge as the ground state moves towards the 
transition state. The resulting model for catalysis invokes tight binding of NADPH 
through ionic interactions between two, symmetry-related K32 residues with the 
2-phosphate and pyrophosphate groups. Loss of an ionic interaction between a 
symmetry-related K32 residue on the other side of the pore and the Glu tail of DHF might 
be the key event that facilitates catalysis. This scenario predicts that the ligands move 
towards a position associated with the correct distance and angle for hydride transfer and 
that solvent may be excluded as well. This unusual mechanism likely arises from the 
need to balance catalysis with the constraints imposed by the 222 symmetry of the active 
site pore. 
1.6 Experimental Mutational Studies 
To investigate the importance of residues involved in binding, site-directed 
mutagenesis experiments were conducted. CAST (complexity analysis of sequence tracts) 
analysis shows that residues K32, K33, S34, G35, A36, Y46, T48, L50, T51, G64, S65, 
V66, Q67, 168, Y69, P70, and A73 line the active site pore.39 So far, mutations on 
residues K32, K33, A36, W38, Y46, T51, S59, H62, G64, S65, V66, Q67,168, and Y69 
have been investigated.2'15'37'40"43 Due to the tetrameric form of R67 DHFR, a single 
mutation on the gene results in four mutations in the protein and the effect of four 
concurrent mutations can be profound on protein stability and ligand binding. For 
example, the cumulative effect of four mutations at residues K32, W38, S59, or H62 
destabilizes at the dimer-dimer interfaces and only dimers are formed.15'37'42'43 Mutations 
at residues K33, Y46, S65, or V66 show less than 5-fold effects on binding and catalysis 
13 
although S65 and V66 are as near the center of the active site pore as the 168 and Y69 
residues.37'40 The S65A mutation did not cause significant changes in the kinetic or ITC 
values, suggesting that the S65 residue is not directly involved in interactions with the 
ligands.40 Also the S65 residue only contributes 5% of the total binding surface created 
by residues 32, 36, 46, and 64-69. 
Residues K32, Q67, 168, and Y69 construct 42% of the surface in the active site 
and form a stripe that establishes the binding and catalytic surface.39 These four residues 
and their symmetric counterparts form two continuous stripes running from one edge of 
the pore to the other.2 These four residues are considered as the most critical residues 
since mutations on any of them result in profound changes in ligand binding and catalysis. 
For example, mutations on the K32 residue destabilize the homo-tetrameric structure.37 
Based on the crystal structure, the Q67 residue has been proposed to form extensive van 
der Waals interactions with the pteridine ring of folate and the Q67H mutant displays 36-
and 110-fold tighter binding to DHF and NADPH, respectively.18'41 However, the tighter 
binding does not necessarily lead to enhanced catalytic efficiency, because binding is 
concurrently tightened at all symmetry-related sites. This leads to substantial substrate 
and cofactor inhibition caused by formation of the nonproductive R67/DHF/DHF and 
R67/NADPH/NADPH complexes. Therefore, a balance between catalysis and inhibition 
exists, which can be perturbed by the mutations. 
Docking studies suggest that Y69 and symmetric counterparts may interact with 
both NADPH and DHF ligands.13 To investigate the importance of the Y69 residue, both 
conservative and non-conservative mutations were examined. The Y69F mutant displays 
8-fold weaker binding to DHF and 22-fold weaker binding to NADPH when compared to 
wild type R67 DHFR while the kcat is 2-fold greater. The less conservative Y69H 
mutation shows increased Km for both ligands, but a 90-fold decrease in &cat.
40 NMR 
studies show that the Y69 residue undergo chemical shifts upon NADP+ binding, 
indicating the Y69 residue may be involved in binding the NADPH ligand. The I68L 
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and I68M mutations weakened the binding to DHF by 4-fold and weakened NADPH 
binding by 7-9 fold.40 The changes in both NADPH and DHF binding suggest that the 
Q67,168, and Y69 residues contribute to the binding of both ligands.40 
These previous mutational studies were carried out on quadruple mutants since 
one mutation in the gene results in four mutations per active site and this typically results 
in large cumulative effects because of the symmetry. To combat this, Howell and 
co-workers created a gene that contained four copies of the R67 monomer.44'45 This 
development allowed the formation of an active monomelic protein (Quad 3) with the 
same number of amino acids as the wild type tetramer. Mutations could now be 
incorporated at a single position in the enzyme. So far, the K32M, Q67H, and Y69F 
asymmetric mutants have been studied. 
The single K32M mutation was tolerated quite well while double mutations 
exhibited different effects. The K32M:A+B (mutation on monomer A and B) and 
K32M:A+C mutants have a reduced kcat but the K32M:A+D mutant has a 4-5 fold 
increase in ^cat.compared to the Quad 3. When the binding of NADPH was monitored 
by fluorescence quenching, titration results showed that Quad 3 and the K32M:A single 
mutation have the lowest Kd values (1.0 and 1.2 uM), indicating that the single site 
mutation has the smallest effect, since the NADPH can presumably still interact with one 
of the non-mutated binding sites. K32M:A+D has a higher Kd value (5.2 uM), but not as 
high as K32M:A+B (9.7 uM) and K32M:A+C (8.4 uM), indicating that the NADPH still 
has two ionic interactions with the K32s on monomer B and C.38 The K32 residues are 
involved in binding DHF as well since the loss of two K32 residues affects the binding 
affinity. Also, when DHF is bound to R67/NADPH:A+B and R67/NADPH:A+C, similar 
kinetic behavior (A;cat and Km) is observed. This highly unusual result suggests that the 
DHF tail is flexible and able to form interactions with K32 from either monomer A or C, 
supporting the fact that the tail of DHF is very flexible as evidenced by the disordered tail 
in the crystallographic structures and NMR studies.18'21'22 
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By far, the most puzzling results were obtained for the Q67 mutations. A Q67H 
single mutant (Q67H:A), three different Q67H double mutants (Q67H:A+B, Q67H:A+C, 
and Q67H:A+D), and a Q67H triple mutant (Q67H:A+B+C) were studied (Table l).46 
The double mutants had a large effect on both DHF and NADPH binding and on their 
cooperativity. However, the formation of R67/NADPH/DHF was not drastically affected. 
These results suggest that the role of the Q67 is to disfavor the formation of the inhibitory 
complexes R67/DHF/DHF and R67/NADPH/NADPH and that the interplay between the 
protein and the ligands provides a funnel towards transition-state formation. Interestingly, 
whether or not the nonproductive complexes would become more favorable could not be 
predicted from the binding constants. Thus, the role of cooperativity in these mutants is 
still not completely understood. But the asymmetric mutations suggest a multiple 
functional role for these residues.38'46'47 After the occupation of the first binding site, the 
proximity of other symmetry-related sites can enhance binding by reduction of the 
associated entropy and/or by reducing the dissociation rate.48"50 









4.0 + 0.3 
3.6 ±0.8 
2.7 + 0.1 
17.7 ±0.8 

















46 + 0.7 
0.88 ±0.06 
0.97 ± 0.04 




2.0 ± 0.02 
2.0 ± 0.05 
1.1 ±0.02 
320 ±16 
20 ± 0.6 
0.64 ±0.1 
Dissociation constant has a unit of uM. The Quad3 is a tandem gene array containing 
four copies of the monomer gene. Q67H:A indicates a single-site mutation while 
Q67H:A+B stands for mutations on monomer A and B. 
The Y69F mutants were the only set to behave as expected, i.e. as the number of 
mutants increased, the binding constants and the rate of catalysis steadily increased. 7 
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Binding of NADPH to the Y69F single or double mutants showed only minor effects. 
The largest effect for a double mutation was only a 3-fold increase in K<\ for Y69F:A+B 
compared to Quad3. As three and four mutations are introduced, the K& values 
correspondingly increase (3.1 and 6.5-fold).47 When binding DHF, a higher concentration 
is required to reach saturation, since an increase in the mutation sites weakens the binding 
interactions.17 Although the docking study does not predict a direct interaction between 
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the hydroxyl group of Y69 and NADPH, loss of the hydroxyl group (Y69F quadruple 
mutation) results in a 20-fold increase in Km for NADPH.
40 In contrast, both the hydroxyl 
group and aromatic ring of Y69 are important for DHF binding as indicated by the Y69F 
and Y69L mutations.47 
In a summary, the E.Coli. chromosomal DHFR uses a well-defined active site, 
specific protein contacts, and domain and floppy-loop movement to facilitate binding and 
catalytic efficiency. R67 DHFR has developed an alternate path to catalysis. It uses a 
positive electrostatic potential to guide the negatively charged ligands to the active site. 
Although its promiscuous binding surface can accommodate NADPH/NADPH, 
DHF/DHF, NADPH/DHF combinations, the unique binding cooperativity ensures 
NADPH binds first to one of four symmetry-related sites. Once bound, NADPH creates a 
local asymmetric environment in the active-site pore that disfavors binding of a second 
NADPH molecule (negative cooperativity), but favors the binding of DHF (positive 
cooperativity). Both of these cooperativities favor the channeling of the binding pathway 
toward formation of the R67/NADPH/DHF productive ternary complex. This inter-ligand 
cooperativity results in a compressed distance between C6 of DHF and C4 of the 
nicotinamide ring. Also, the R67 DHFR has evolved its own evolutionary pathway by 
using a more stable transition state (endo) for catalysis. Although R67 DHFR has a 
180-fold slower hydride transfer rate than the well-evolved E.Coli. chromosomal DHFR, 
it has a 3-fold higher kcal and 30-fold higher efficiency (fccat /̂ m(DHF)) than the D27S 
mutated chromosomal DHFR.11 This convergence suggests that general acid catalysis is 
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an important part of the chromosomal DHFR's catalytic mechanism. But, due to the 
symmetry inside the active site of R67 DHFR, an acid catalysis site would disrupt the 
formation of the productive ternary complex. Therefore, it selects an alternate route by 
using solvent water as the protonation source of the N5 position. 
The source of the enzyme's binding cooperativity is still a mystery, yet it is 
essential for its correct function. Typically, allostery (i.e. conformational changes upon 
binding) contributes significantly to cooperative binding. Although the backbone 
structure remains stable upon ligand binding, too few structures of R67 DHFR exist to 
determine the local changes in the enzyme. Therefore, we performed a series of 




2.1 Computational Chemistry 
Computational chemistry is a branch of chemistry that uses computing power to 
solve chemical problems. It converts theoretical chemistry into efficient computer 
programs that can calculate the structural and functional properties of different types of 
molecules. It can provide explanations and additional information about chemical 
experiments as well as predict unobserved chemical phenomena. Computational methods 
can be used in both static and dynamic situations and the computing time increases 
rapidly with the size of the system. The system studied can range from a single molecule 
to a large biological system. Therefore, computational chemistry methods can employ 
highly accurate calculations or very approximate approaches. Highly accurate methods 
such as ab initio calculations, are based entirely on theory from first principles and are 
typically feasible only for small systems. Other methods are called empirical or 
semi-empirical approaches because they use experimental results to approximate the 
behavior of large systems. Based on the approach employed to calculate the potential 
energy, computational studies can be classified as quantum mechanics (QM) or molecular 
mechanics (MM). 
2.2 Quantum Mechanics and Molecular Mechanics 
In this study, both quantum mechanics (QM) and molecular mechanics (MM) 
methods were used. Quantum mechanics is a set of principles describing physical 
systems at the atomic and subatomic levels and has been experimentally verified to have 
a high degree of accuracy.51 Classical physics (often refers to the Newtonian physics) can 
be seen as an approximation to quantum physics for large numbers of particles and the 
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laws of quantum mechanics can be applied to classical physics for systems of an 
appropriate size or quantum numbers. Quantum mechanics was initially developed to 
provide a better explanation of the atom. It is important for the understanding of how 
individual atoms combine covalently to form chemicals or molecules. Quantum 
mechanics can provide quantitative insight into ionic and covalent bonding processes by 
explicitly showing which molecules are energetically favorable and by how much.52 
GAUSSIAN is a popular and widely-used electronic structure program first released in 
1970 and has been continually updated for the past 38 years.53 It enhanced the growth of 
computational chemistry, particularly in the area of ab initio calculations. 
Both ab initio and semi-empirical approaches involve approximations. These 
range from simplified forms of the first-principles equations that are easier or faster to 
solve, to fundamental approximations to the underlying equations that are required to 
achieve any solution to them at all. For example, most ab initio calculations make the 
Born-Oppenheimer approximation, which greatly simplifies the underlying Schrodinger 
Equation by freezing the nuclei in place during the calculation. In principle, ab initio 
methods eventually converge to the exact solution of the underlying equations as the 
number of approximations is reduced. In practice, however, it is impossible to eliminate 
all approximations, and residual error inevitably remains. The goal of computational 
chemistry is to minimize this residual error while keeping the calculations tractable. 
Molecular mechanics uses Newtonian mechanics to describe the molecular 
systems and permits the study of the relationships between structure, function and 
dynamics at the atomic level.54 Molecular mechanics can be used to study small 
molecules as well as large biological systems or material assemblies with many 
thousands to millions of atoms. Since huge amounts of atoms are normally involved, it is 
not feasible to apply quantum mechanics to these systems. Therefore, molecular models 
typically describe atoms as point charges with an associated mass. The potential energy is 
calculated using a force field. Each particle has an assigned radius, polarizability, and a 
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constant net charge, which is generally derived from quantum calculations and/or 
experiment. The interactions between neighboring atoms are described by spring-like 
interactions to represent chemical bonds. Atoms are assigned coordinates in Cartesian 
space or in internal coordinates, and can also be assigned velocities in dynamical 
simulations. The atomic velocities are also related to the temperature of the system, a 
macroscopic quantity. The system internal energy (U), a thermodynamic quantity equal 
to the sum of the potential and kinetic energies, is a collective mathematical expression 
known as the potential energy function which is related to the motion of the molecules. 
Current generations of force fields (or Potential Energy Functions) provide a 
reasonable balance between accuracy and computational efficiency. They are often 
calibrated to experimental results and quantum mechanical calculations of small model 
compounds. Their ability to reproduce physical properties measured experimentally, such 
as X-ray or NMR structural data, dynamic data obtained from spectroscopy or inelastic 
neutron scattering, and thermodynamic data, is tested. Therefore, empirical potential 
energy functions are more tractable and computationally less demanding than quantum 
mechanics; but, this increase in speed comes at a cost. Numerous approximations are 
introduced which lead to certain limitations. 
2.3 CHARMM Force Fields 
In this research, the CHARMM program and CHARMM force field55'56 are used. 
CHARMM (Chemistry at HARvard Macromolecular Mechanics) is a general and flexible 
molecular simulation and modeling program that uses classical (empirical and 
semi-empirical) energy functions for molecular systems of many different classes, sizes, 
and levels of heterogeneity and complexity.55'56 The CHARMM force fields and 
associated analysis packages are widely used for molecular dynamics and the core of the 
program is based on the empirical potential energy function which is used for energy 
minimization, molecular dynamics simulations, vibrational analysis and thermodynamic 
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calculations. In addition, there are interfaces to several quantum mechanical programs 
which allow one to do mixed QM and MM calculations. The CHARMM program also 
enables the user to compare structures, evaluate energies, and calculate time series and 
correlation functions. It can treat systems ranging in size from small individual organic 
molecules to large proteins and DNA molecules in solution. It was developed in the 
laboratory of Professor Martin Karplus at Harvard University over 25 years ago. The first 
article describing the CHARMM program was published in 1983.56 Today, contributors 
continue to improve and enhance the capabilities of the program. 
U(R) = ]T Kb (b - b0)
2 + Y, Ke(6- 0O)




+ ^T Ar<p(l + cos(n<p-5))+ ^T Ku(ai - OJ0)2 
dihedrals impropers 
' i r / / ? m i n \ 1 2 ARm i n \ 6 l a a ) « + I W" ir) -2(ir) +£$* 2 UmA?M)(Eql) 
non-bonded*. L v lJ ' \ V / } V) residues 
pairs 
The general form of the potential energy function most commonly used in 
CHARMM is based on fixed point charges (Eq. I).55 The potential energy, f/(/?), is a 
sum over individual terms representing the internal and nonbonded contributions as a 
function of the atomic coordinates. The internal terms include bond (b), angle (0), 
Urey-Bradley (UB, S), dihedral angle (#>), improper angle (G>), and backbone torsional 
correction (CMAP, cp, if/). The parameters K^, K$, #UB, K9 and K^ are the respective force 
constants and are obtained from studies of small model compounds and comparisons to the 
geometry and gas phase vibrational spectra (IR and Raman spectroscopy), supplemented 
with ab initio quantum calculations. The variables bo, 0o, So, 8, and a>o are the respective 
equilibrium values. 
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Fig. 5. A schematic diagram of the terms in the potential energy function. The energy 
terms include: a) Bonded potential, b) Angle potential, c) Dihedral angle potential, d) 
Improper potential, e) Van der Waals potential, f) Electrostatic potential. 
The harmonic bond potential is commonly selected to model a covalent bond in a 
molecular structure. The force constant, Kb, determines the strength of the bond and the 
equilibrium bond length {bo) can be inferred from high resolution crystal structures or 
microwave spectroscopy data in addition to the methods mentioned above (Fig. 5a). The 
bond angle is defined among three consecutive atoms and the bond angle is indicated by 6 
(Fig. 5b). There are two types of angle potentials used by most molecular dynamics 
programs. The CHARMM force field uses harmonic angle potential functions (Eq. 1) and 
other programs use cosine harmonic angle potential functions (e.g. GROMOS96). In the 
CHARMM force field, an additional Urey-Bradley potential function is added to the 
angle in order to restrain the motions of the bonds involved in the angle (Eq. 1). The 
reference length of the distance between particles / and k is given by So and the 
corresponding force constant is given by KUB- Therefore, the Urey-Bradley potential 
introduces a virtual bond between atoms / and k and therefore is also called the 
1,3-nonbonded potential (Fig. 6a). The force associated with this potential can be derived 
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similar to the bond potential. It allows for better reproduction of the vibrational 
frequencies of the system (e.g. water molecule). 
When four atoms are involved, two types of torsion potentials will be introduced: 
the dihedral angle potential and the improper potential. Both potentials involve four atoms 
but have different atom connections (Fig. 5 c-d). The dihedral angle potential applies to 
consecutive atoms and is mostly used to constrain the rotation around a bond (Eq. 1). The 
Kcp is the force constant belonging to the cosine potential, cp is the current angle between 
the planes of atom i, j , k and atom j , k, I, while 5 is the angle where the potential is at a 
minimum, and n is the multiplicity (i.e. the number of minima as the bond is rotated 
360°). It is often possible that the rotation around a bond has local and global minimums. 
In order to accommodate this type of behavior, the potential is generalized through 
individual harmonic functions, each having its own force constant {Kcp), multiplicity (n) 
and reference angle (S). The improper potential is also calculated from the angle of two 
planes (Fig. 5d). By placing atom i in the center, the torsion angle is still defined by 
planes of atoms i, j , k and atoms j , k, I. This definition allows the same equation for 
dihedral angle potential to be used to compute the improper potential with minimum 
changes to the molecular dynamics code. The improper torsion potential is mainly used to 
maintain planarity in a molecular structure. Hence, it only has one minimum and a 
harmonic potential is used (Eq. 1). Both the Urey-Bradley and improper dihedral terms 
are used to optimize the fit to vibrational spectra and out-of-plane motions. In the polar 
hydrogen models, the improper dihedral angle term is also required to prevent inversion 
of chirality. Although the improper dihedral term is used very generally in the CHARMM 
force fields, the Urey-Bradley term tends to be used only in special cases.55 
The energy term representing the contribution of non-bonded interactions in the 
CHARMM potential energy function has two components, the van der Waals interaction 
(Fig. 6b) and the electrostatic interaction (Fig. 5f). Non-bonded interactions are calculated 
between all atom pairs within a user-specified inter-atomic cutoff distance, except for 
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covalently bonded atom pairs (1,2 interactions) and atom pairs separated by two covalent 
bonds (1,3 interactions). The most commonly used potential for modeling the van der 
Waals interaction is the Lennard-Jones (LJ) potential and it is used to treat the repulsion 
and attractive interactions between atoms (Eq. 1). The £™in term is the Lennard-Jones 
minimum energy (well depth) of the potential between atoms i and j . rij is the inter-atomic 
distance (Fig. 6b). The attractive interaction has a longer range (r,y) than the repulsive 
interaction, but as the distance becomes short, the repulsive interaction becomes 
dominant. /?™m is the distance at which the LJ reaches zero and attraction and repulsion 
are equally balanced. Typically, £™in and Rf-m are obtained by combining the values 
for individual atom types using the geometric mean and arithmetic means (i.e. £™in = 
( £ min £ min a n d ^min = ( i ? min + Rm™y2).
55 
Fig. 6. Diagram of the a) Urey-Bradley interaction and b) van der Waals interaction. 
The van der Waals interaction is one of the most important contributors to the 
stability of biological systems. The repulsive force arises at short distances where the 
electron-electron interaction is strong. The attractive force arises from fluctuations in the 
charge distribution in the electron clouds.55 Each of these two effects is equal to zero at 
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infinite atomic separation r and become significant as the distance decreases. Positioning 
of the atoms at the optimal distances stabilizes the system. The attractive potential 
(—r~-6) has been experimentally validated while the repulsive interaction (r^12) has 
different power numbers, but 12 is the most often used power number for easy calculation, 
since it is the square of the attractive part. 
In the electrostatic interaction, the atoms are treated as point charges (<?, and qj) and 
therefore the electrostatic potential between a pair of atoms is represented by a Coulomb 
potential (Fig. 5f). The ry term is the distance between atoms i and j and the relative 
dielectric constant, s, is set to 1 in calculations with explicit solvent, corresponding to the 
permittivity of vacuum (so=8.8542xl012 C^N^m-2). In addition, for the protein backbone, 
a grid-based dihedral energy correction map (CMAP) has been implemented.55 This 
correction increases the accuracy of force fields to treat conformational energies 
especially for geometries significantly far away from the minimum-energy or equilibrium 
values. The use of CMAP yields more accurate dynamical information on the protein.58'59 
The empirical potential energy function has several limitations, which may affect 
the results of the calculated potential energy or dynamic character. One of the most 
important is that no drastic changes in electronic structure are allowed, i.e., no events like 
bond forming or breaking can be modeled. Therefore, mixed QM/MM force fields are 
under development in a number of laboratories to overcome this limitation. A second 
source of error is the use of a fixed set of atom types to determine the parameters of the 
force field. Atom types are used to define an atom in a particular bonding situation, for 
example an aliphatic carbon atom in an sp3 bonding situation has different properties than a 
carbon atom found in the histidine ring. Instead of representing each atom in the molecule 
as unique with its own set of parameters, atoms in similar bonding situations are grouped 
together in order to minimize the number of atom types. This simplication can lead to 
type-specific errors. The properties of certain atoms, like aliphatic carbon or hydrogen 
atoms, are less sensitive to their surroundings and a single set of parameters may work 
26 
quite well, while other atoms like oxygen and nitrogen are much more influenced by their 
neighboring atoms. These atoms require more types and parameters to account for the 
different bonding environments. 
Another possible source of error is the pair-wise additive approximation introduced 
to decrease the computational demand. In this approximation, the interaction energy 
between one atom and the rest of the system is calculated as a sum of pair-wise interactions, 
or as if the pair of atoms do not see the other atoms in the system. The simultaneous 
interaction between three or more atoms is not calculated, so certain polarization effects 
are not explicitly included in the force field. This omission can lead to subtle differences 
between calculated and experimental results, for example, the calculated pK shifts of 
ionizable amino acid side chains caused by the electrostatic field of the protein disagree 
with those determined experimentally. 
Another important point to take into consideration is that the potential energy 
function does not include entropic effects. Thus, the calculated minimum value of E does 
not necessarily correspond to the equilibrium, or most probable structure; which instead 
corresponds to the free energy minimum. Since experiments are generally carried out 
under isothermal-isobaric conditions (constant pressure, constant system size and constant 
temperature) the equilibrium state corresponds to the minimum of the Gibb's Free Energy, 
G. While a single energy calculation ignores entropic effects, these are included in 
molecular dynamics simulations. 
2.4 Molecular Dynamics Simulation 
Molecular Dynamics (MD) simulations can provide detailed information on the 
fluctuations and conformational changes of proteins and nucleic acids. These methods are 
now routinely used to investigate the structure, dynamics and thermodynamics of 
biological molecules and their complexes. They are also used in the determination of 
structures from X-ray crystallography and from NMR experiments. Molecular dynamics 
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simulations are based on Newton's second law (Eq. 2) where F, is the force exerted on 
atom i and m, and a, are the mass and acceleration of atom i. The force can also be 
expressed as the gradient of the potential energy (V) of the system.60 
Ft = miUt = -VtV (Eq. 2) 
In the molecular dynamics simulation, the time dependent behavior of a molecular 
system is obtained by integrating Newton's equations of motion using one of the 
numerical integrators and the potential energy function. This results in a time series of 
conformations which is called a trajectory. The most straightforward integration method 
is the Verlet algorithm which uses positions and accelerations at time t and the positions 
from time t — St to calculate new positions at time t + St (Eq. 5). It is a sum of two 
individual position equations based on the time t (Eq. 3, 4). The Verlet algorithm does not 
involve explicit velocities and storage requirements for the Verlet algorithm are modest. 
r{t + St) = r(t) + v(t)8t + ± a(t)8t2 (Eq. 3) 
r{t- St) = r(t)- v(t)St + \a(t)St2 (Eq. 4) 
r{t + St) = 2r(t) - r(t - St) + a(t)8t2 (Eq. 5) 
The Verlet leap-frog algorithm is a variant of the original Verlet scheme and will 
be employed in this study. In this algorithm, the velocities are first calculated at time 
t + -St (Eq. 6). And these velocities are used to calculate the positions, r, at time t+St 
(Eq. 7). In this way, the velocities leap over the positions, and then the positions leap 
over the velocities.61 The advantage of this algorithm is that the velocities are explicitly 
calculated. This is useful when molecular dynamics simulations require properties (such 
as the sum of potential and kinetic energy) that depend on position and velocity at time (t). 
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The velocity at time t can be calculated by Eq. 8. 
v {t + -2 5t) = v {t - i 5t) + a(t)St (Eq. 6) 
r (t + 5t) = r (t) + y (t + i St) 8t (Eq. 7) 
p(t) = i [v (t - itft) + V (t + \St)] (Eq. 8) 
Most molecular dynamics simulations are performed under conditions of constant 
N (fixed number of atoms), V (fixed volume), and E (fixed energy), but more recent 
methods perform simulations at constant N, T (fixed temperature), and P (fixed pressure) 
to better mimic experimental conditions. A detailed procedure for setup and runing of a 
molecular dynamics simulation is described below. 
2.4.1 Initialization 
An initial configuration of the system is required to begin a molecular dynamics 
simulation. This includes having a starting structure which can be obtained from X-ray, 
NMR, docking, or homology modeling. The initial configuration must be carefully 
chosen since this can influence the quality and/or stability of the simulation. Generally, 
configurations that mostly mimic the expected structures are chosen as a starting structure, 
otherwise the simulation may end up in other local minima or less stable conformations. 
Once the system has been selected or built, an energy minimization of the structure is 
often necessary to remove any strong van der Waals interactions which may lead to local 
structural distortion or result in an unstable simulation. Methods which minimize the 
potential energy include steepest descent (SD) and conjugate gradient (CG). The steepest 
descent approach is the simplest of the gradient methods and the minimum energy is 
arrived via a zig-zag manner. New search directions are orthogonal to the previous. In the 
conjugate gradient algorithm, during each minimization step, the gradient is calculated 
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and used as additional information for computing the new direction (i.e. refined direction) 
of the minimization. Molecular dynamics programs allow a selection from different 
algorithms depending on the system requirement and both the SD and CG methods are 
employed in this study. 
The next step is to solvate the minimized structure by placing it into a 
pre-equilibrated water box of suitable shape and size. The structure is placed into the 
center of the water box and any water molecules that overlap with the protein are 
removed (Fig. 7a). 
Fig. 7. The solvation and periodic boundary condition of dynamics simulation, a) 
The protein is placed in the center of a truncated octahedron water box of ~13,000 H20 
molecules, b) Under periodic boundary conditions, when the protein comes out one side 
of the water box, it will enter in the symmetric side, which keeps the protein in a 
continuous solvent environment. 
After solvation, another energy minimization should be done with the protein 
fixed in its energy minimized state. This allows the water molecules to readjust to the 
presence of the protein molecule. In this study, the TIP3P explicit water model and a 
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water box of a truncated octahedron shape are used. The TIP3P model has three 
interaction sites, corresponding to the three atoms on the water molecule and the bond 
distance (0.9572 A) and angle (104.52°) are the same as the corresponding experimental 
values. It is commonly employed in MD simulations because of its simplicity and 
efficiency. 
Periodic boundary conditions (PBC) are usually used to reduce the number of 
water molecules in a simulation. During the simulation, if the protein moves out of the 
water box, it will enter into the symmetric side of the primary water box and the water 
molecules will move away to create space for the protein (Fig. 7b). This procedure 
ensures that the protein is continuously solvated and significantly reduces the size of the 
water box. However, the size of the primary water box still needs to be sufficient enough 
that the primary protein does not interact with its symmetric counterparts. 
2.4.2 Equilibration 
Initially, the velocities of all the atoms are assigned in accordance with a low 
temperature and the protein is limited to minimum movements. During the equilibration 
phase, new velocities are assigned periodically at a slightly higher temperature. This 
process is repeated until the desired temperature (300K) is reached. After that the 
simulation of the solvated system continues and during this phase, several properties are 
monitored such as the structure, pressure, temperature, and energy. The equilibration 
phase continues until these properties become stable with respect to time. If the 
temperature increases or decreases significantly, the velocities can be rescaled so that the 
temperature returns to near its desired value. 
2.4.3 Production Dynamics 
The main part of the simulation is the production phase. In this phase, a dynamics 
simulation is performed for the desired time length and a trajectory is saved for later 
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analysis. The maximum timestep of the system depends on the fastest motions. The 
highest frequency motions in a system are the bond stretching terms, in particular the 
bonds involving hydrogens.64 But these motions, which consume large amounts of 
computing time, are of the least interest. Therefore, different algorithms (e.g. SHAKE) 
have been developed as a solution to this dilemma.65 SHAKE is an efficient algorithm 
which removes the highest frequency motions from the system by freezing the bond 
lengths involving hydrogen, without affecting the intrinsic accuracy of the simulations. It 
has been shown that the application of SHAKE to bond stretching degrees of freedom 
does not affect the overall properties of the system.60 
The non-bonded terms are calculated by looping through all possible 
combinations of atoms i and j . Therefore, significant computing time will be spent 
calculating the non-bonded terms. For this reason, a cut-off distance is usually employed 
to exclude the much weaker long-range non-bonded interactions. But, the straightforward 
application of cut-off distance will create a discontinuity for atom pairs which are 
separated by a distance close to the boundary. At one time step, they may be within the 
cut-off distance and contribute to the energy and force calculations. At the next time step, 
they may be out of the cut-off distance although only a very tiny movement occured. To 
avoid these abrupt changes, the CHARMM program uses a switching and/or shifting 
function(s) to treat the non-bonded terms. 
The switching function introduces a second cut-off distance. For distances within 
the inner threshold, the energy and forces are calculated without modification and 
interactions beyond the outer threshold are ignored. For the distances in between the two 
cut-off distances, the interactions are scaled smoothly to zero as the distance approaches 
the outer boundary.60 The shifting function modifies the energy over the whole cut-off 
distance and the energy approaches zero at this cut-off distance. The shifting function is a 
smoother method but the switching function is generally a more preferred method for 
calculating the van der Waals interactions because the Lennard-Jones force decreases 
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dramatically as the distance increases. The switching function only affects the energy in 
the range between the inner and outer threshold, while the energy and forces are modified 
for all distances in the shifting function. 
None of the above methods are appropriate for treating electrostatic interactions. 
The electrostatic interaction is a function of 1/r, but inclusion of all atoms for a direct 
summation is not practical. Therefore, the Ewald summation is the method of choice for 
computing electrostatic interactions in systems with periodic boundary conditions. It 
avoids the problems associated with the use of a cut-off radius and there is no need for 
switching or shifting functions.60 The Particle-Mesh Ewald summation splits the problem 
into two parts: a direct summation of the short-ranged potential in normal space (r-part) 
and a summation in Fourier space of the long-range term.66 It has been proved to have a 
force accuracy of 10"4 with only a 30-40% increase in the computing time over methods 
involving a cut-off distance.67 
2.5 Conformational Analyses 
After the productive dynamics, the system conformational stability is examined 
using various built-in functions of the CHARMM program. The Root-Mean-Square 
Deviation (RMSD) computes the distances between all (or selected) atoms in two 
corresponding sets of coordinates and is an overall measurement of how much the two 
structures differ (Eq. 9). 
RMSD = ^^(rf-rf)2 (Eq. 9) 
The r" term is the coordinates of atom i in structure A and rf is the coordinates 
of the same atom in structure B. It can be used to calculate the time-series difference 
between trajectory structures and the starting structure or a single-frame difference 
between two conformations. In the RMSD calculation, it is always necessary to orient the 
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structure (or atom selections of interest) to the reference structure (or atom selections) so 
that the RMSD with respect to the reference becomes a minimum. This process avoids 
the calculation of any meaningless RMSDs because the two structures occupy different 
coordinate systems. The structural orientation is also necessary in merging the trajectory 
files since the protein may move around during the simulation. Therefore, an orientation 
of the trajectory conformations to a reference structure (often the minimized solvated 
structure) allows a focus on the protein conformational/dynamical changes rather than a 
shifting or rotational motion through the solvent. 
The radius of gyration measures the size of a protein. It is calculated as the root 
mean square distance of the objects' parts from its center and is a good indication of the 
compactness of globular proteins (Eq. 10). 
Radius of Gyration = j—'Zi(ri — rcm)
2 (Eq. 10) 
The r, - rcm is the distance between atom i and the center of mass of the molecule. 
Through a time-series radius of gyration plot, the well-maintained shape of a protein is 
represented by a relatively flat line indicating its unchanged compactness. Any increase or 
decrease in the radius of gyration indicates the expansion or collapse of the protein, which 
suggests that a conformational change has occurred. Both the RMSD and the radius of 
gyration are widely used to analyze the stability of simulations. 
The calculation of Root-Mean-Square fluctuations (RMSF) is used to represent 
the flexibility of all the atoms in the system studied (Eq. 11). 
RMSF = ̂ Zf{r[-rrf (Eq. 11) 
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The rf is the coordinate of atom i in a certain frame while the r"ve is the same 
atom i in the averaged structure. Their difference tells how far away atom i is from its 
average in this particular frame. This difference is calculated for atom i through the whole 
trajectory (or particular time period of interest) to represent the average fluctuation of 
atom i from its average value. The RMSF for a given residue is an average of the RMSF 
values for all the atoms in the residue and provides useful information on the residue 
flexibility. 
Other conformational analyses can be done using residue covariance, visual 
inspection, and contacts in the system. The residue covariance calculates the correlated 
motion of a dynamics trajectory for selected pairs of atoms or atom groups (i.e. residue). 
The normalized covariance matrix is given by Eq. 12. The E[Rj] and E[Rk] terms are 
the respective mean for atom j and k. The covariance matrix is used to examine the 
correlated motions of the residues. Visual inspections of the system studied may include 
looking at structural overlaps or protein movement during a trajectory. The residue or 




Hjk = E[(Rj - E[Rj]XRk - E[Rk])] (Eq. 13) 
= E[Rj] - E[Rj]E[Rk] 
2.6 Ligand Binding Free Energy 
2.6.1 MM-PBSA 
The ligand binding free energy can be calculated using the molecular mechanics 
Poisson-Boltzmann surface area (MM-PBSA) method.68 The MM-PBSA approach does 
not involve empirical parameters in the free energy calculation and this makes it a 
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promising method. The MM-PBSA method has been successfully applied to the binding 
energy estimation of many biological systems including protein-protein and 
protein-ligand systems.68"77 In this approach, a thermodynamic cycle (Fig. 8) is 
considered and the binding free energy is calculated as the sum of the gas-phase energies, 
solvation free energies, and entropic contributions averaged over a series of snapshots 
from the MD trajectory (Eq. 14). AGgas is the interaction energy between A and B in 
the gas phase and the enthalpy contribution (AHgas) is calculated from the average 
molecular mechanical gas-phase energies (AEMM) (Eq. 15). The AG^olv, AGfoil7, and 
AG£%V are the solvation free energies of A, B, and AB which are estimated using the 
Poisson-Boltzmann surface area approach with proper dielectrics of water (80) and 
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Fig. 8. The diagram of a thermodynamic cycle. The aqu stands for the solvated state 
and gas stands for the gas phase. 
^binding — AGgas — AGsolv — AGsolv + AGsolv 
= AHaas - TAS - AG£BSA - AGfBSA + AG
AB 
'gas 
= AHgas ~ TAS + AAGPB + AAGSA 
PBSA 
(Eq. 14) 
&Hgas *** hEgas — AEMM — AEintra + AEelectrostatic + AEvdw 
AAGPB = AG?* - (AG£B + AG$B) 





Common estimations of the entropy term include normal-mode analysis, 
quasi-harmonic analysis, ~ and the quasi-Gaussian approach. The atomic fluctuation 
matrix in the quasi-harmonic entropy analysis is obtained from the snapshots of an MD 
simulation. For a series of compounds with similar structures and binding modes, the 
entropy contribution can be omitted if only the relative order of binding affinities are of 
interest. However, if the absolute binding free energy is needed or the compounds are 
very different, the entropy term must be included.78 However, serious problems may 
occur in the quasi-harmonic analysis if the states are not well sampled during the MD 
simulation. 
T the binding free energy estimation can be rewritten as the free energy difference 
between the bound and unbound states (Eq. 18, 19). For an enzyme with two ligands 
bound, the binding free energy of the first ligand (AGlinding) is calculated by taking the 
free energy difference between the ternary complex (enzyme+ligandl+ligand2) and the 
unbound state (enzyme+ligang2 and ligandl) (Eq. 21). Calculation of the binding free 
energy of ligand2 (AG^inding) is vice versa (Eq. 22). 
'^'-'binding "complex "enzyme "ligand 
G = EMM + AGPB + AGNS — TS 
z-MM = ^intra "•" ̂ electrostatic "•" ^vdW 
^binding = ^complex ~ ^enz+lig2 ~ ^ligl (Eq. 21) 
^binding = "complex ~ "enz+ligl ~ "Ug2 (Eq. 22) 
In the MM-PBSA calculations, all waters are removed from each snapshot. The 
CHARMM program is then used for calculation of the various terms. EMM is the 
average molecular mechanical free energy in the gas-phase and is estimated from the 





average polar solvation free energy, AGNS is the average non-polar solvation free energy, 
calculated from the equation AGNS = 0.00542 kcal/mol/A
2xSA + 0.92 kcal/mol, SA is 
the solvent-accessible surface area (SA), and S is the gas phase entropy estimated from 
quasi-harmonic analysis. To obtain these averages, snapshots 4ps apart were taken from 
the equilibrated period of the MD trajectory. The quasi-harmonic entropy estimation was 
also performed for the selected time period and all of the atoms are included. 
2.6.2 MM-GBSA 
In addition to the binding free energy calculation, the same dynamics trajectory 
can also be used to decompose the binding free energy into residue contributions using a 
generalized Born (GB) model.85"87 The MM-GBSA approach is much faster than the 
MM-PBSA calculations and allows decomposition at the atomic level, followed by 
summations over atom groups such as residues, backbones, or side-chains.75 This analysis 
provides insight into the origin of the binding energy and can identify the backbone 
contributions of the most important residues involved in ligand binding. Similar to the 
MM-PBSA approach, the GB model also contains the same energy terms (Eq. 23). 
&Gbinding ~ AE^ + AG£fS + AG5" 
= AEintra + AEvdW + &Eelec + AGelec,solv + AG£pfSOiv (Eq. 23) 
The difference is in the AE[^ra (intra-molecular energy) term, which is zero in 
this equation, since the internal energy will not make a contribution to ligand binding. 
Equation 23 calculates the residue contribution to the ligand, while the backbone and 
side-chain decompositions are determined by different atom selections. For the ternary 
complexes, the snapshots used for the binding free energy decomposition calculation on 
ligand 1 do not include the second ligand and vice versa. 
38 
QQ QQ 
In this method, the GB-MV2 model ' is used to calculate the electrostatic 
solvation contribution to the binding free energy. Since the decomposition is used to 
estimate the residue (or backbone, side-chain) contribution to the ligand binding energy, 
one half of a pairwise electrostatic interaction comes from the protein and the other half 
from the ligand. Therefore, the contribution of atom i to the ligand binding energy is 
given by Eq. 24 where j loops over all the atoms of the ligand and rtj is the distance 
between the two atoms. Similarly, one-half of the pairwise interaction between the 
protein and ligand is applied to the van der Waals interaction energies to avoid 
double-counting. 
*«-£** 
The GB-MV2 approach uses the Still et. al. expression to calculate the 
electrostatic solvation energy term (Eq. 25).85' ° 
*GleleCiSOlv =
 fcf:+^X~r m === (Eq-25) 
k = -166.0(£^ojute — £joivent) with energies in kcal/mol and distance in A. The 
Ssoiute and Ssoivent are the dielectric constants of the solute and the solvent (i.e. 1 and 80, 
respectively), a, and a, are the Born radii of atoms i andy. The constant Ks is equal to 8 in 
GB-MV2. This pairwise expression allows us to determine the polar solvation energy 
contribution of atom i. 
The nonpolar contribution to the solvation free energy is assumed to be 
proportional to the solvent accessible surface area (SA) (i.e. AGnp S0jl7 = a x SA).
OJ This 
approximation comes from the fact that the solvation energy of saturated nonpolar 
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hydrocarbons is linearly related to the SA. ' In this study, a value of 0.0072 
kcal/mol/A2 was used for the parameter a in the nonpolar solvation energy calculation 
(Eq. 26).75'90'93 The SA of each atom i in the enzyme-ligand complex (SAl,E+L) and in the 
enzyme (SAl,E) are calculated by the CHARMM program. 
MLsoiv = ° x i.SAUEL - SAl'E) (Eq. 26) 
The total residue binding free energy can be obtained by summing' these atomic 
contributions over the atoms of a residue. Also, these energy contributions can be 
summed into the backbone or side-chains of a given residue. 
2.7 Electrostatic Potential 
For certain systems, the electrostatic interactions play an important role in protein 
conformation or ligand binding. An electrostatic potential analysis was performed by 
using the APBS (adaptive Poisson-Boltzmann solver)94 and VMD (Visual Molecular 
Dynamics)95 programs. First, the structure is assigned charge and radius parameters from 
the CHARMM force fields by the PDB2PQR program,96'97 which is a Python software 
package that automates structure preparation from PDB format to PQR format. The 
electrostatic properties of the bimolecular systems (in PQR format) are then evaluated 
through solution of the Poisson-Boltzmann equation (PBE) by the adaptive 
Poisson-Boltzmann solver (APBS). It is one of the most popular continuum models for 
describing electrostatic interactions and allows the investigation of molecules with tens to 




TRUNCATED LIGAND STUDY 
3.1 Introduction 
As a first step to understanding the unique binding patterns of R67 DHFR, only 
truncated ligands were used in the simulations, since the flexible tails would require 
significant sampling. The X-ray crystal structure (PDB ID: 1VIF) contains folate but the 
actual substrate is DHF, therefore, both FOL and DHF were employed in the simulations. 
Studies on chromosomal DHFR suggest that DHF is protonated at N5 (DHFH+) prior to 
hydride transfer, but there is no proton donor group in the active site of R67 DHFR.18 
Thus, water-protonated DHF (DHFH+) may be the actual compound bound by the 
enzyme.1'15 Therefore, DHFH+ was also used as a substrate in our simulations.25 For FOL, 
DHF, and DHFH+, the pteridine ring (PTE) region was utilized and named tFOL (t for 
truncated), tDHF, and tDHFH+, respectively (Fig. 35 in Appendix). For NADPH, the 
nicotinamide and attached ribose ring (NR) were included. The tFOL ligand can bind in 
two distinct conformations in the active site: 1) the re conformation (R67/tFOL); 2) the si 
conformation (R67/tFOL'). Thus, simulations were performed on both single tFOL 
conformations. 
The starting coordinates were taken from the X-ray crystal structure containing 
FOL (PDB ID: 1VIF) or from the docked structures.13'18 The first 18 residues of each 
monomer are disordered in the X-ray crystal structure, and thus, were not included. This 
truncation should have a minimal effect on enzyme activity, as R67 DHFR remains fully 
active after cleavage of the first 16 residues.14 The R67/NR/NR complex was achieved by 
a y, z-coordinate flip of the NR ligand in R67/NR/tFOL. The single ligand complex 
R67/NR was achieved by deletion of the PTE from the docked complex.13 A complete list 
of simulated complexes is given in Table 2. 
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Table 2. The simulated complexes involving truncated ligands 
apo -Enzyme Binary Complex Non-Productive Productive 
apo-DEFR R67AFOL R67/tFOL/tFOL R67/NRAFOL 
R67/tFOL' R67/tDHF/tDHF R67/NR/tDHF 
R67/tDHF R67/NR/NR R67/NR/tDHFH+ 
R67/tDHFH+ 
R67/NR 
The binary complexes contain only one ligand. The ternary complexes include 
non-productive combinations (two substrates or two cofactors which do not yield product) 
and productive combinations (one cofactor and one substrate which yield product). 
3.2 Methods 
For the MD simulations, the CHARMM program,56 the CHARMM param22 all 
atom force field, and TIP3P water model were used for all simulations. Parameters for 
NADPH are included in the CHARMM force field and parameters for FOL and DHF 
no 
were determined previously. Charges and parameters for the truncated ligands were 
calculated using the B3LYP/6-31G* level of theory with the Gaussian03 program.53 
Adequate solvation of the protein adds -13,000 waters to the 240 amino acid residue 
simulations. The number of water molecules is larger than expected for a protein of 240 
residues, because the channel in the center significantly increases the protein size. A van 
der Waals switching function between 8 and 11 A, a cutoff of 13 A for the non-bonded 
list, and periodic boundary conditions were employed. All bonds involving hydrogen 
were constrained with the SHAKE algorithm and the electrostatic interactions in the 
system were computed by the particle-mesh-Ewald (PME) method. The temperature was 
raised to 298K during the 100 ps of equilibration dynamics. A time step of 2 fs was used, 
and the velocities rescaled as necessary to maintain the temperature at 298+/-5K. After 
the first 100 ps equilibration, 5 ns production dynamics were performed. 
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3.3 Results and Discussion 
3.3.1 Stability of Simulations 
After the simulation, the backbone root-mean-square deviations (RMSDs) were 
calculated from the simulation trajectories. For most complexes, the protein shows a 
steady increase in RMSD during the first 1.5 ns, indicating that the protein is still 
equilibrating. After 2 ns, the RMSDs remain relatively stable and below 2 A (Fig. 9 a-b), 
which indicates that the trajectories are fluctuating around an average structure. Thus, 
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Fig. 9. Backbone RMSDs and radius of gyration of simulated complexes, a-b): 
Backbone RMSD vs. time for all simulated complexes, c-d): Radius of gyration vs. time 
for all the simulated complexes 
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The radius of gyration vs. time was flat for each complex, indicating stable and 
compact structures through the whole trajectory (Fig. 9 c-d). Both of these results 
indicate that for all the complexes there were no major conformational changes and that 
the tetramer remained stable under the simulation conditions. 
3.3.2 Ligand Fluctuations 
While all well-behaved systems will have stable protein backbone RMSDs, the 
same is not necessarily true for the ligands. The calculated RMSD for the PTE ligands in 
the binary complexes fluctuate at a much higher level (Fig. 10). 
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• R67/tDHF (tDHF) 
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• R67/tDHF/tDHF(tDHF1) 




Fig. 10. Ligand RMSDs for selected complexes containing the PTE ligand(s). Ligands 
in the R67/tFOL, R67/tFOL\ and R67ADHF have increased RMSDs in the first half of 
simulation, indicating their conformational changes while the flat RMSDs for them in the 
second half suggest relatively stable conformations are reached. 
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Trajectory inspections showed that the position of the NR ligand is stable for 
different complexes. The PTE ligand is flexible when the sole occupant of the active site 
(Fig. 11a). The tFOL ligand rotates 90° to a more stable vertical conformation, while 
tFOL' flips 180° compared to its original conformation and moves deeper into the active 
site. Although tDHF maintains its original conformation, it travels to the edge of the 
active site. However, once a second ligand (PTE or NR) is added to the complex, the 
lower RMSDs show that the PTE loses much of its flexibility (Fig. 10). 
Fig. 11. Overlap of the simulated complexes, a): Side view of the overlapped average 
structures: R67AFOL (yellow), R67AFOL' (blue), R67/tDHF (purple), R67/tFOL/tFOL 
(red) and R67/tDHF/tDHF (green). Residues Q67s are displayed in orange and the 
corresponding starting structure of the R67/PTE complexes are displayed as line 
representations, b): Side view of the X-ray crystal structure (2RK1, orange) and 
simulated average structures: R67/NRAFOL (red), R67/NRADHF (yellow), 
R67/NR/tDHFH+ (green), R67/NR (blue), and R67/NR/NR (purple). 
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The greater flexibility of the PTE ligand in the binary complexes may result from 
the lack of additional contacts provided by the missing tail. On the other hand, this lack 
of a consensus binding site agrees with the high experimental K^ values for DHF, since 
both indicate the presence of only weak interactions between the active site and DHF. An 
exception is found for the R67/tDHFH+ where the tDHFH+ remained relatively stable 
compared to the starting structure and has low a ligand RMSD. 
For hydride transfer to occur, the C6 atom on the PTE ligand needs to be within 3 
A of the hydrogen (NH4) of the NR ligand. Therefore, the hydride transfer distance was 
monitored for the productive complexes. In each productive complex, the PTE moved 
from its initial position to a place where it could n stack with the NR ligand (Fig. lib). 
The average distances for hydride transfer for the three productive complexes 
(R67/NR/tFOL, R67/NR/tDHF, and R67/NR/tDHFH+) are 3.18 A, 3.01 A, and 2.89 A, 
respectively. An overlap with the newly resolved ternary X-ray crystal structure 
R67/NADP+/DHF (PDB ID: 2RK1)22 showed exceptional agreement between the ligand 
position in the X-ray and those of the MD average structures (Fig. lib). 
Interestingly, in the three productive complexes, tDHFH+ did not shift towards the 
nicotinamide ring until 2.5 ns while the tDHF and tFOL ligands moved to the NR side 
during equilibration (Fig. 12). This indicates that tDHFH+ is not favored inside the active 
site. If the enzyme does not bind tDHFH+, protonation would have to occur inside the 
active site. Since water is the only protonation source, trajectory files of R67/NR/tDHF 
were analyzed to determine the number of water molecules which could protonate the 
tDHF on its N5 atom (within 2 A distance). Results show that a hydrogen atom from 
water molecule is within protonation distance 33.3% of the simulation time, indicating 
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Fig. 12. Hydride transfer distances between PTE (C6) and NR (NH4) for the three 
productive complexes R67/NRAFOL, R67/NR/tDHF, and R67/NR/tDHFH+. 
3.3.3 Comparison of the Backbone Structures 
The most surprising result from this study is the stability of the protein backbone 
across the different complexes. Overlap of the average structures for each simulation with 
the X-ray crystal structure shows surprisingly little variation in the backbone 
conformation, except for residues 19-21 on the N-terminus and their symmetric 
counterparts (Fig. 13 and Fig. 36 in Appendix). Calculation of the RMSDs between the 
backbones of the average structures and the X-ray crystal structure and amongst each 
other gives values of 0.9 to 1.9 A (Table 3). When the flexible N-terminal residues 19-21 
and counter-parts are excluded, the RMSDs drop to a range of 0.3 to 0.6 A, supporting 
the observation that the backbones are very similar for all complexes studied. This 
finding is in accordance with X-ray studies where the RMSD between the Q67H mutated 
R67 DHFR with NADP+ bound (PDB ID: 2P4T) and the apo-enzyme crystal structure 
(PDB ID: 2GQV) is only 0.3 A." These results clearly demonstrate that backbone 
conformational changes are not involved upon ligand binding. The backbone of R67 
DHFR simply acts as a scaffold for ligand binding and the cooperativity must be 
achieved through other mechanisms. 
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Fig. 13. Backbone overlap of the X-ray crystal structure and some of the simulated 
complexes (the rest can be found in Fig. 36 in Appendix). Structures of the simulated 
complexes are the averaged conformations. Except for the flexible N-terminus, all 
backbone structures have well-overlap. 
Although the protein backbone in the average structures remains unchanged 
through different complexes, the backbone structure is not a fixed rigid frame. Instead, 
the backbone is able to fluctuate slightly around the average. This type of fluctuation can 
be seen as a protein breathing motion and does not significantly affect the overall ligand 
binding conformation. It appears that the detailed interaction between the ligand the 
residues inside the active pore may be altered. And it may also aid the DHF ligand 
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3.3.4 Comparison of Binding Energies 
The free energies were calculated using the MM-PBSA method. For each 
trajectory, a free energy was calculated for the entire complex, Genz+iig or Genz+iigi+iig2, 
binary and ternary complexes respectively; for the enzyme by itself, Genz; and for the 
individual ligands, Gug, or Gi;gi and Gng2. In the case of the ternary complexes, free 
energies for the two possible binary complexes, G(enz+iigi)t and G(enz+iig2)t, were also 
calculated. 
The binding free energies (AG) were then calculated by taking the difference 
between the average free energies. The binding energy of a ligand to the apo-enzyme can 
be calculated from either the binary complex simulation (AG(i;g)b, Eq. 27) or a ternary 
complex simulation (AG(ugi)bt or AG(ug2)bt, Eq. 28). Note that Genz is different for each 
simulation since the protein conformations sampled during each trajectory will be slightly 
different. Equation 29 was applied to the ternary complex simulations in order to 
determine the binding energy of a ligand to a binary complex (AG(iigi)t or AG(ng2)t). Due to 
the unreliability of quasi harmonic entropy calculations,100 energies which exclude this 
contribution were examined first. The results are presented in Table 4. 
AG(ug)b = Genz+iig - Genz - Giig (Eq. 27) 
AG(iigX)bt = G(enz+iigx)t - Genz - G)igx x = 1 or 2 (Eq. 28) 
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The binding free energies can be evaluated in several different ways. First, AG(iig)b 
(binding to binary complex) can be compared to AG(iigX)t (binding to ternary complex), 
which will indicate if the presence of a second ligand has had an effect on the binding 
energies. Note that for the homoligand ternary complexes, two binding energies, one for 
each binding site, will be calculated. The sum of these two numbers is not the total 
binding energy of the complex. The binding energies AG(PTE)b of the PTE ligands in 
R67/tFOL, R67/tFOL', and R67/tDHF have similar values of -6.1, -9.3, and -7.0 kcal/mol, 
respectively. In contrast, the tDHFH+ ligand has a binding energy of 1.4 kcal/mol, 
indicating that tDHFH+ is not favored in the active site. In R67/tFOL/tFOL, one tFOL has 
a binding energy (AG(tFOLi)t) of -9.1 kcal/mol, which is similar to the values for R67/tFOL 
and R67/tFOL'; but, the second tFOL ligand has a much higher binding energy (AG(tFOL2)t) 
of -16.7 kcal/mol. Thus, one site exhibits no change in binding energy, while the second 
site does, reproducing the positive binding cooperativity. The same trend was also found 
for the two ligands in R67/tDHF/tDHF, where the binding energies (AG(tDHFi)t and 
AG(tDHF2)t) are -6.6 and -12.8 kcal/mol, compared to the -7.0 kcal/mol for AG(DHF)t>-
NR in the R67/NR complex has a binding energy (AG(NR)b) of -34.3 kcal/mol. In 
R67/NR/NR, one NR has a similar binding energy (AG(NRi)t) of-33.6 kcal/mol, while the 
second NR has a lower binding energy (AG(NR2)0 of -17.2 kcal/mol, which matches with 
the negative cooperativity. The NR ligands in the productive complexes (R67/NR/tFOL, 
R67/NR/tDHF, and R67/tDHFH+) all have strong binding energies (AG(NR)t), ranging 
from -35.3 kcal/mol to -37.9 kcal/mol. The tFOL and tDHF in the productive complex 
now have binding energies (AG(PTE)I) of -15.8 and -16.4 kcal/mol, which are much 
stronger than for the binary complexes (AG(PTE)b)- These results match with the 
NADPH/DHF positive binding cooperativity mentioned previously. The tDHFH+ in the 
productive complex has a binding energy (AG(tDHFH+)t) of -4.3 kcal/mol, which is 
significantly lower than the binding energies of the PTE ligands in the other two 
productive complexes, even though all three ligands occupy the same binding spot (Fig. 
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1 lb). Thus, as mentioned earlier, the protonation process may take place within the active 
site, since the protein will most likely bind a non-protonated DHF. Alternatively, 
N5-protonation may be concerted with hydride transfer . 
A second comparison is to calculate the total binding energy for a complex 
assuming no cooperativity (AG(tot)b) and to calculate a total binding energy using the 
ternary complex simulations (AG(tol)(). AG(tot)b is the sum of AG(i;gi)b + AG(Hg2)b. The 
AG(tot)t is the sum of AG(hgi)bt and AG(iig2)t for a given ternary complex, R67/ligl/lig2. For 
R67/tFOL/tFOL, AG(tot)t is -21.6 kcal/mol while AG(tot)b is -12.2 kcal/mol. A similar trend 
is observed for the R67/tDHF/tDHF and the productive complexes. Having AG(tot)b's so 
much lower than the corresponding AG(tot)t's indicates positive cooperativity. These 
values are unable to distinguish whether ligand-ligand interactions or conformational 
changes are contributing to the increased binding. In R67/NR/NR, if the two NR ligands 
occupied symmetric binding sites, the total binding energy would be -68.6 kcal/mol 
(AG(tot)b)- However, the total binding energy from the ternary complex, AG(tot)t, is -49.7 
kcal/mol, reproducing the experimentally observed negative cooperativity. The fact that 
the binding energies AG(tot)b and AG(tot)t do not match is not surprising considering that 
the second tFOL, tDHF, or NR do not occupy a symmetrical site with respect to the other 
ligand. Since observed trends match the experimental data, conclusions based on our 
simulations should be accurate, but more importantly, the cooperativity can be 
reproduced using only the truncated portions of the ligands. Experimental studies on 
truncated and modified ligands also support this conclusion.101 
A last comparison can be made between the binary binding energy and ternary 
binding energy calculated from the ternary complex simulation, AG(Hgi)bt and AG(iigi)t, 
respectively. Only ligand-ligand interactions will contribute to differences in these 
numbers, since the same protein conformations are used to calculate both energies. The 
ligand binary binding energies AG(Hgi)bt and AG(i;g2)bt are noticeably weaker than the 
ternary binding energies AG(Hgi)t and AG(iig2)t. Thus, inter-ligand interactions help stabilize 
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both ligands. The binding energy of one of the PTE ligands (AG(FTEi)bt) in the 
R67/PTE/PTE complexes is worse than AG(i;g)b for the corresponding true binary 
complex. This ligand most likely occupies a less favorable binding site in the ternary 
complex. The other PTE ligand has a higher binding energy (AG(PTE2)bt) that is larger than 
for the first PTE ligand (AG(FTEi)bt) and than the AG(PTE)b energies. The increase in 
binding between AG(PTEi)bt and AG(PTEi)t is 3.7kcal/mol or higher indicating that 
inter-ligand interactions play a crucial role in the observed positive cooperativity. 
Calorimetric data showed that enthalpy contributed to the positive cooperativity of 
FOL/FOL, FOL/NADPH and DHF/NADP+, which agrees with ligand-ligand interactions 
being an important part of the cooperativity. However, enthalpy was not involved in the 
positive cooperativity of DHF/DHF, which disagrees with our results. For the 
R67/NR/NR case, the binding energies only increase 1 kcal/mol for each ligand. The lack 
of overlap can account for this reduced increase (Fig. lib). While in the case where 
overlap exists, i.e. the productive complexes, the binding energy increase for NR from 
binary to ternary ranges from 5.7 to 6.1 kcal/mol, supporting the importance of 
inter-ligand interactions. 
Quasi-harmonic calculations were performed on each complex to obtain the solute 
entropy contribution and the corrected binding energies are listed in parentheses in Table 
3. The negative cooperativity trend observed for R67/NR/NR and the positive 
cooperativity trend for R67/PTE/PTE or R67/NR/PTE from comparing AGnig)b and 
AG(iig)t still remain valid after the addition of the entropy term. The quasi-harmonic 
entropy term generally lowers the binding energy of NR while increasing the binding 
energy of the PTE. Thus, the positive cooperativity observed using AG(tot)b and AG(tot)t is 
lost for R67/DHF/DHF and R67/NR/PTE complexes when entropy is included. The 
missing tail prevents formation of stable interactions with the outer edge of the enzyme, 
and can lead to a possible over estimation of the entropy for PTE. However, the 
application of the truncated ligands successfully avoided complex sampling issues due to 
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tail movements and the simulations were able to reproduce both the positive and negative 
cooperativities in most cases. 
3.3.5 Side Chain Contacts and Side Chain Conformations 
The analysis of residue contacts between the ligand and the protein reveals the 
important residues involved in binding. Residues within 4 A of the surface of the ligand 
were considered and the results show that most residues involved in binding match those 
identified by experimental mutational studies, i.e. K32, Q67, 168 and Y69 (Table 5). 
Contacts are also noted for S65 and V66, which mutational studies had indicated were 
not important for binding. Interestingly, for identical ligands, the number of residue 
contacts and location of these residues within the four possible monomers varied little 
among the different complexes. 
The contacts for the NR ligand in both the binary complex (R67/NR) and ternary 
complexes (R67/NR/NR, R67/NR/PTE) are relatively conserved (residues K32, A36, S65, 
V66, and Q67). The contacts to the PTE ligands in the productive complexes are also 
conserved (residues Q67,168, and Y69). The second NR ligand in R67/NR/NR loses two 
important contacts (residues Y169 and Q367) compared to the first NR. This alteration 
causes the second NR to bind slightly differently and lowers its binding energy. The 
residue contacts of the PTE ligands in the binary complexes are widely distributed 
because of the flexibility of the PTE ring. The residue contacts in R67/PTE/PTE are not 
symmetric for the two PTE ligands, since they are not occupying symmetrically-related 
binding sites. Certain residues are seen contacting both PTE ligands, suggesting that they 
may be involved in binding both ligands. 
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Table 5. Residue contacts between the protein and ligands. 
Residue Contacts 
Ligand I Ligand II 
R67AFOL 265, 267, 367,368, 369 
R67/IFOL' 67, 68, 167, 168, 367 
R67ADHF 67,265, 266, 351, 370 
R67/tDHFH+ 67, 767, 267, 268, 366, 367,368 
R67/tFOL/tFOL 267, 367,368 67, 68,69, 167, (367) 
R67/tDHF/tDHF 67,68, 69, 368 68,167,367,368,369 
R67/NR 32,36, 67, 68,69,265,266,267,367, 368 
R67/NR/NR 32,36, 67,68,69,265,266, 267,367, 368 132,136,167,168,267, 268,365,366 
R67/NRAFOL 32,36,67,68,69,265,266, 267,368 68,167,367,368,369 
R67/NRADHF 32,36,67,68,69,265,266, 267,368 68,167,367,368,369 
R67/NRADHFH+ 32,36, 67,68,69,265,266, (267), 368 68,167,367,368,369 
f Ligand I refers to the first appeared ligand in the ternary complex and ligand II is the 
second appeared ligand in the ternary complex, e.g. in R67/NR/tFOL, ligand I is the NR 
ligand while ligand II is the tFOL ligand. The conserved residue contacts to the NR and 
PTE ligands are shown in bold and unconsented contacts displayed in italics. Residues in 
parenthesis are less significant resides (i.e. less atoms are within cutoff distance to the 
surface of the ligands). 
The side chains of residues V66 and 168 do not appear to contribute to the binding 
cooperativity since the conformations of these residues show no change in the overlap of 
the average structures from different complexes (Fig. 14). This behavior is not observed 
for residue Q67. In the apoenzyme, the Q67 from each monomer is sticking out into the 
active pore. However, in order to make room for a ligand, Q67 must fold down, so that its 
side chain is packed against the side of the active site. Similar conformations for Q67 
(sticking out and folded down) are observed in the apo (PDB ID: 2GQV) and ternary 
(PDB ID: 2RK1) X-ray structures.22'102 
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Fig. 14. Conformations of the key residues (V66, Q67, 168, Y69 and symmetric 
counterparts) in the average structures, (a) Overlap of apo-DHFR (red), R67ADHF 
(yellow), R67/tFOL/tFOL (green), and R67/tDHF/tDHF (blue). All Q67s are displayed in 
licorice representation, (b) Overlap of apo-DHFR (red), R67/NR (yellow), R67/NR/NR 
(green), and R67/NR/tDHF (blue). 
In the R67/tDHF complex, one Q67 has to bend out of the way. In 
R67/tFOL/tFOL, Q167 and Q267 are both bent out of the way and in R67/tDHF/tDHF, 
all the Q67s are folded down. The bending of Q67, Q267, and Q367 for R67AFOL is due 
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to the perpendicular orientation of the PTE ring and will most likely not be possible for 
the full ligand. Complexes with NR ligand(s) have a similar pattern, with Q67 and Q167 
folded down in R67/NR and R67/NR/NR, and all four Q67s folded down in 
R67/NR/tDHF. This bending mechanism of Q67 allows more room for a second ligand 
and may contribute to the positive cooperativity of the ligands. 
This bending motion is able to explain the changes in the dissociation constants in 
the asymmetric Q67H mutational studies (Table l).46 The single mutant (Q67H:A) binds 
the first NADPH slightly more strongly and binds the second NADPH much less strongly. 
Most likely, the histidine, which can 7i-stack with the nicotinamide ring, causes the first 
NADPH to move deeper into the active site. This movement leads to an increased steric 
effect for the second NADPH. When two mutations occupy vertical positions in the 
active site (Q67:A+B), both NADPHs can rc-stack with the histidine on its own side, thus 
lowering both K& values. The diagonal mutation (Q67H:A+D) causes both K& values to 
increase, possibly due to changes in the H-bond pattern. The H-bonds between Q67 on 
monomer D and the two NADPHs may not be able to form, since histidine has a less 
flexible side chain than glutamine. The Q67H:A+C horizontal mutation causes the first 
K& to increase and the second K& to decrease. These mutations are on the same side as one 
of the ligands. The first NR will 7t-stack with one histidine and be hydrogen bonded to the 
second, causing it to stick out into the active site and interfere with binding of a second 
NR. 
The Q67H mutations no longer exhibit positive cooperativity for the binding of 
DHF. The Q67H:A single mutation causes a significant decrease in the first Kd, most 
likely due to 7i-stacking. The Q67H:A+B double mutant has similar K& values for both 
DHF ligands. The two histidines, which are on the same side of the active site as the two 
DHF's, are able to sandwich the two pteridine rings. The diagonal mutation Q67H:A+D 
has a similar Kd for the first DHF as Q67H:A and Q67H:A+B but a 10 times higher Kd 
for the second DHF. This increase may be from the first DHF 3i-stacking with both 
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mutated Q67s, leaving the second DHF no possible 7i-stacking interactions. The reason 
behind the abnormal increase in the second K& of Q67H:A+C could be from one of the 
histdines being perpendicular to the other to avoid steric clashes between the two 
histidines. The first DHF could then interact with the perpendicular histidine leaving little 
room for a second DHF molecule. The possibility of perpendicular binding is supported 
by the simulations on the PTE binary complexes, which showed that the pteridine ring is 
prone to rotate 90° from its binding position in the ternary complex. When triple 
mutations are involved, the Ka values for both NADPH and DHF change dramatically. 
The explanation for these observations is still unclear. 
In addition to Q67, the Y69 residue may be involved in the negative cooperativity 
of the NR ligands. In R67/NR, Y69 has moved slightly towards the nicotinamide ring and 
the same Y69 movement was found in R67/NR/NR and R67/NR/PTE (Fig. 14b). 
Displacement of Y69 toward NADPH was also seen in the productive X-ray crystal 
structure (PDB ID: 2RK1).22 The symmetric Y169 does not move toward the second NR 
ligand in the R67/NR/NR complex, which may contribute to the weaker binding of the 
second NR. The strong binding NR ligands in R67/NR, R67/NR/NR, and R67/NR/PTE 
all occupy a similar binding position (Fig. lib) and are in close contact with Y69, while 
the weak binding NR in R67/NR/NR is missing contacts to Y169 and Q367, as 
mentioned previously. 
A study of the hydrogen bonding network provides additional insight into the 
binding patterns result of the R67/NR/NR and R67/NR/tDHF complexes (Fig. 15). In the 
R67/NR/NR complex, the closest distance between the two NR ligands is 2.7 A, and, as 
mentioned previously, the rings do not overlap. The ribose ring has a perpendicular 
position with respect to the nicotinamide ring and prevents the ribose ring from crossing 
the barrier caused by the Q67's while DHF is able to cross the barrier since its two rings 
are relatively flexible with respect to each other. Therefore, the second NR (Fig 15a, right) 
in the R67/NR/NR complex will bind slightly off-center, and the Q167 residue is flipped 
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180° when compared to the Q67 residue interacting with the first NR (Fig. 15a, left). In 
addition, the strong 0---H—O bond (Q67-Y69) becomes a weaker N—H---0 bond 
(Q167-Y169), and this may be why the Y169 does not shift toward the second NR ligand. 
Finally, the second NR has longer hydrogen bonds and lacks the additional H-bonds to 
residue 1168. Overall, steric interactions between the two NR ligands causes one of the 
ligands to adopt a less favorable binding position, which lacks key hydrogen bonds to the 
protein, and therefore negative binding cooperativity is observed. 
(b) V266 1368 V366 
Fig. 15. Hydrogen bonding networks in a) R67/NR/NR and b) R67/NR/tDHF. The 
ligands are shown in both licorice and surface representations. 
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In the productive complex R67/NR/tDHF, the hydrogen bonds to NR are the same 
as observed in the X-ray structure (PDB ID: 2RK1) and the R67/NR and R67/NR/NR 
average structures. The binding of the tDHF ligand should also be favorable as it has 
three strong hydrogen bonds to residue 1368 (Fig. 15b). A ligand "clamp", defined as the 
hydrogen-bonded groups of Y169-Q167-Q367-Y369 and Y69-Q69-Q267-Y267, were 
observed in the X-ray structure (PDB ID: 2RK1)22 and require that both Q67 residues of 
a group be folded-down and on the same side of the active site. The 
Y169-Q167-Q367-Y369 hydrogen-bonded group was observed for the productive 
complex, R67/NR/tDHF, but the second group, Y69-Q69-Q267-Y267, was not found. 
The use of the truncated DHF caused the Q267 residue to only partially fold down and 
prevented formation of the necessary hydrogen bonds. This result matches with the 
apo-enzyme X-ray (PDB ID: 2RH2) observation that the hydrogen-bond pattern of R67 
DHFR is altered when one of the Q67's adopts a different conformation.22 
Besides the residue-ligand contacts, all heavy atom contacts between the protein 
and ligand and between the ligands were calculated using a 6.5 A cutoff (Fig 16). Not 
surprisingly, the larger NR ligand always has more contacts (>500) with the protein than 
the PTE ligands (-300). The inter-ligand contacts for the PTE/PTE and NR/PTE 
complexes are approximately 150. However, the R67/NR/NR complex has only 7 
contacts between the two NR ligands. The number of contacts helps explain the positive 
cooperativity for R67/PTE/PTE and R67/NR/PTE and the negative cooperativity of 
R67/NR/NR. In the PTE/PTE and NR/PTE complexes, the rings can stack within the 
active site, increasing the favorability of binding. In the NR/NR complex, the rings 
cannot stack because of their bulky size. Thus, ligand-ligand interactions appear to be a 
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Fig. 16. Contacts between protein-ligand or ligand-ligand for the simulated complexes. 
Calculations were performed for the average structures with a cutoff distance of 6.5 A 
and exclusion of hydrogens. 
3.3.6 Electrostatic Potential Analysis 
A previous calculation of the electrostatic potential analysis of R67 DHFR 
predicted a positively-charged active site pore from the K32 and K33 residues located 
near the edge of the pore.13 This positive potential should be attractive to the two 
negatively-charged ligands, since NADPH has a net charge of -4, while folate/DHF has a 
net charge of -2 . Thus, the negative charge on the outside of the torus may aid in 
1 ^ 
electrostatic guidance. The electrostatic potential could also potentially play a role in 
binding cooperativity. Therefore, electrostatic potential analyses were performed by using 
the APBS94 and VMD95 programs. The active site pore of the MD average structure of 
the apo-DHFR has the same positively-charged area as the X-ray structure (Fig. 17).13 
The net charges of the truncated ligands are -1 for NR and +1 for tDHFH+. Although the 
tFOL and tDHF ligands have no charge, electrostatic potential analysis shows a partial 
negative charge around the edge of the pteridine ring. Therefore, the active site pore 
provides an ideal environment for the negatively-charged NR and the partially 
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negatively-charged tFOL and tDHF, but not for the positively-charged tDHFH+. Upon 
binding a NR ligand (R67/NR), the active site becomes more negative, decreasing the 
possible interactions between a second negatively-charged NR ligand, possibly 
contributing to the negative cooperativity. 
R67/tFOL R67/tDHF 
Fig. 17. Electrostatic potential surfaces of the ligands (tFOL, tDHF, tDHFH+, DHF, 
NR) and simulated complexes (a/w-DHFR, R67/NR, R67/tFOL, R67/tDHF). The blue 
color indicates positively charged electrostatic potential while red stands for the 
negatively charged potential. The electrostatic potentials of R67/NR, R67/tFOL, and 
R67ADHF are shown with ligand bound. 
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Active sites of complexes with a single PTE ligand (R67/tFOL and R67/tDHF) 
show no observable changes in their electrostatic potential analysis, possibly because 
tFOL and tDHF are not as negatively charged as NR. Observation of the electrostatic 
potential of PTE shows that direct overlap of two PTE rings or PTE and nicotinamide is 
not favored; but, a slight offset would lead to attractive interactions between the rings. In 
accordance with this conclusion, the overlap of the two PTEs is twisted in the average 
structures of R67/tFOL/tFOL and R67/tDHF/tDHF (Fig. 11a). This favorable interaction 
between the two PTEs further supports the idea that ligand-ligand interactions have a 
large effect on the binding cooperativity of this enzyme. 
The tFOL and tDHF ligands are less affected by the change in the electrostatic 
potential surface caused by NR, since tFOL and tDHF have less negative charge. 
However, the possible stacking interaction between the PTE ring and the nicotinamide 
ring of NR should have a positive effect on the binding energy and contribute to the 
observed positive cooperativity. This strategy is not possible for R67/NR/tDHFH+ since 
the ring stacking interaction will be less favorable and binding of tDHFH+ will be 
disfavored by the still mainly positive active site. 
In accordance with the findings presented here, we propose a "push-eject" model 
for this particular enzyme and its unique binding cooperativity. The backbone and most 
side chains within the active site act as a scaffold and the four equivalent Q67s act as 
springs. They are pushed down by the ligand(s), which are attracted to the positively 
charged active site pore. After catalysis, NADP+ is less favored in the active site than 
NADPH due to the decrease in its negative charge to -3 and a decrease in the 
ligand-ligand stacking interactions. Therefore, we predict that NADP+ will be ejected by 
the Q67 "springs" and then THF will dissociate. This supposition is confirmed by the 
much higher Kd value (29 uM) of NADP+ compared to THF (4.8 uM) in the 
R67/NADP+/THF complex.20 
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3.3.7 Comparison of Dynamics 
In the past, it was assumed that allostery was the result of a conformational 
change. The current view is that allostery can also be caused entropically without an 
obvious conformational alteration. In this case, ligand binding causes either a shift in 
the dynamical sampling of local minima or causes a change in the flexibility of the 
protein. For R67 DHFR, clearly a conformational change is not involved in the binding 
cooperativity, while ligand-ligand interactions are important. Changes in the dynamics 
could also contribute to the allostery of this enzyme. This possibility is investigated by 
examining root-mean-square fluctuations (RMSFs), correlated motions and correlations 
in the RMSD's between structures in a given trajectory. 
The root-mean-square fluctuations (RMSF) calculate the overall flexibility of 
each residue of the protein. Residues 19, 20, 21, 78 and counterparts are excluded from 
these calculations due to their large flexibility. Analysis shows that the fluctuations 
between different complexes are similar, but decrease slightly when one ligand is bound. 
The average RMSF is 0.85 A for the apo-enzyme and drops slightly to 0.81 A when one 
tDHF is bound or to 0.80 A when NR is bound. (Fig. 18). In addition, the same pattern is 
observed for each monomer within the same complex in which the terminal residues 
fluctuate more than the middle buried residues. Three major peaks can be found on the 
RMS fluctuation plots which correspond to residues M26, K33-S34, and N49-L50. These 
residues are located on the outer surface of the protein and their long side chains are 
facing into solvent, thus having high fluctuations. For the most part, residues identified as 
being important in binding have low fluctuations regardless of ligand(s) bound. For 
residue K32 and its symmetrical counterparts, the average fluctuation is 0.8-0.9 A. While 
for residues V66, Q67, 168, and Y69 the average fluctuations ranged from 0.6-0.8 A. A 
few Q67 residues have fluctuations outside this range and correspond to the Q67s that are 
sticking out into the active site. These residues are not folded down upon ligand(s) 
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Fig. 18. RMS fluctuations of the simulated complexes. Residues 19, 20, 21, 78, and 
repeating counterparts are not shown due to their high RMSF values. 
Surprisingly, the binding of a second tDHF to form R67/tDHF/tDHF causes the 
o 
RMSF to go back up to 0.85 A. Therefore, dynamics could contribute to the positive 
cooperativity due to a possible increase in entropy upon binding of the second tDHF. 
Interestingly, a set of the residues with increased fluctuations border on one of the DHF's 
but are distant from the binding site of the single tDHF in the binary complex (Fig. 19). 
As might be expected, residues on the surface are about equally split between those that 
have decreased fluctuations and those that have increased fluctuations. These changes 
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should average out overall. For the NR/NR and productive complex the RMSF only 
changes to 0.81 A and 0.82A, respectively and entropy is most likely not a factor in 
cooperativity. 
Fig. 19. Changes in RMS fluctuations upon binding of a second tDHF. Residues with 
increased fluctuations are in red, decreased blue, and no change gray. The tDHF from the 
binary complex is in yellow, while the two tDHF's from the ternary complex are in green. 
Covariance analysis reveals areas of correlated motions. When comparing 
covariance maps for different complexes, both similar and different correlation patterns 
can be observed (Fig. 20). For all complexes, there are 9 common positive correlated 
motions within each monomer due to the strand-strand interactions between the 5 
p-strands within each monomer. The other few negligible positive covariations occur 
between the 310 helix turn or loop structures and the P-strands, simply because these 
structures connect the different P-strands and thus move with them. Between the 
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monomers, there are also areas of positive covariance. These positive correlated motions 
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Fig. 20. Covariance matrices for the R67 DHFR complexes: a) apo-DHFR, b) 
R67AFOL', c) R67/NR/NR. The covariance has a value from most correlated (1.0) to 
least correlated (-1.0) and displayed from red to blue. 
No significant differences in the correlated motions are observed when comparing 
apo-DHFR to the binary complexes and the ternary PTE complexes. The massive 
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negative covariance in R67/tFOL' may come from the flipping motion of the tFOL' ligand. 
The R67/NR/NR and three productive complexes have more area of negative covariance 
than the a/w-DHFR, particularly between monomers. The ligands, which fill the active 
site, can act as a communications network between different areas of the protein. 
However, no set pattern to these changes could be determined and thus the negative 
covariance probably does not contribute to the cooperative binding. 
An additional method for examining dynamical behavior is to calculate RMSD's 
between different structures in a trajectory (Fig. 21). Comparisons can then be made 
between different trajectories. An overall increase in the RMSD's should indicate that that 
complex is more flexible and vice versa. The binary tDHF and NR complexes have 
reduced RMSD's compared to the apo-enzyme, in agreement with the RMSF data. The 
tDHF/tDHF ternary complex has similar RMSD's to the tDHF binary complex, 
suggesting that binding of the second tDHF doesn't cause any change in the dynamical 
behavior of the protein. However, entropy could still be contributing to the positive 
cooperativity. There is clearly an entropy penalty for binding the first tDHF. Since the 
second tDHF either increases flexibility or doesn't change it, the second tDHF does not 
have to pay an entropy penalty and will thus have a more favorable binding energy. In the 
R67/NR/NR and R67/NRADHF complexes, the RMSDs increased, though they still seem 
to be slightly lower than those observed for the apo-enzyme. Provided this RMSD 
increase is related to entropy, then the entropy change would be favorable and support 
positive cooperativity. Since the R67/NR/NR complex exhibits negative binding 
cooperativity, dynamics are still clearly not important in determining the source of this 
cooperativity. For the productive complex, it is possible that dynamics does contribute 




Fig. 21. Trajectory RMSDs between selected complexes. Values are calculated from 
60 structures on each 50 ps of the last 3 ns MD trajectory. 
3.4 Conclusions 
Initial analysis shows that our simulations are stable and in agreement with 
experimental data. In particular, the important residues involved in ligand binding match 
those from the experimental mutational studies. In addition, binding free energies are able 
to correctly reproduce the positive and negative cooperativities, despite the use of 
truncated ligands. Examination of the possible sources of the cooperativity revealed that 
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the cooperativity is not the result of a backbone conformational change. In addition, the 
side chains of K32, V66, and 168 and their counterparts do not appear to be involved in 
cooperativity. Overlap of the average structures show that these residues maintain the 
same conformation in each complex. Exceptions are found for Q67 and Y69; where Q67 
can fold down to make room for the ligand in the active site and Y69 can shift toward NR 
to create a stronger hydrogen bond. Residue Y69 appears to contribute to the negative 
cooperativity of the NR ligand. 
For the NR/PTE and PTE/PTE complexes, the large number of inter-ligand 
contacts clearly contributes to their positive cooperativity. In agreement with the 
simulations, the electrostatic potential surfaces predict a preference for shifted-stacking to 
maximize the inter-ligand interactions. The lack of stacking observed in the R67/NR/NR 
complex is most likely due to bad steric interactions between the ligands. Thus, the main 
source of negative cooperativity comes from ligand-ligand interactions. Along with 
ligand-ligand interactions, alterations in the dynamical behavior of the enzyme contribute 
to the positive cooperativity of the tDHF/tDHF complexes and possibly to the productive 
complex as well. 
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CHAPTER IV 
FULL LIGAND STUDY 
4.1 Introduction 
Complexes containing full ligands were investigated to further understand 
whether the fluctuations of the ligand tails have a significant effect on ligand bindings 
and cooperativities. The R67/DHF models were obtained from docked structures (D4-D5, 
D7, D9, D13-14, D19, D22-D25)13 and the R67/NADPH complexes came from two 
docked structures (N33, N96) and one X-ray crystal structure (NX).13'22 The 
R67/DHF/DHF and R67/NADPH/NADPH complexes are generated by proper 
transformation of the first ligand. The R67/N96/N96 and R67/NX/NX complexes were 
generated from the NADPH ternary complexes. In addition, one of the NX ligands from 
the R67/NX/NX average structure was used to build a new R67/NX2 binary complex. In 
modeling the R67/DHF/DHF complexes, DHFs from the same conformation (R67/D5/D5, 
etc) as well as DHFs from mixed conformations (R67/D5/D7, etc) were used to represent 
all possible binding patterns. The productive complexes R67/NADPH/DHF are a mixture 
of currently available NADPH (N96 and NX) and DHF (D5, D7, D9, and D14) docked 
conformations since the tail orientation of the DHF ligand is still disordered in the 
productive ternary X-ray crystal structure (PDB ID: 2RK1).22 
The eleven docked DHF ligands have four major tail conformations while their 
pteridine ring positions are similar and situated in the center of the active site (Fig. 22). 
Because of the four distinct tail conformations of the DHF ligand, the ternary complexes 
(R67/DHF/DHF, R67/NADPH/DHF) were generated by selecting D5, D7, D9, and D14 
as representations of the four conformations of DHF. Also, the R67/D13/D13 and 
R67/D19/D19 were built to increase the sample size. 
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Fig. 22. The four major conformations of the DHF ligands from the docking study, a) 
Back view of the active site with DHF tail facing out. b) Side view of the active site 
channel. D14 is displayed in red and D7 in blue. Structures in yellow are D4, D9, and 
D13, while structures in green include DHF5, 19, and 22-25. The Q67s are shown in 
orange and the K32 residues are shown in purple. 
In the truncated ligand simulations, the PTE ligand exhibited side-occupation of 
the active site pore. Thus, R67/DHF models with an altered ligand position (D5a, D5b, 
etc) were simulated as well. Position "a" has DHF occupying the side of the pore while 
position "b" has DHF binding even deeper into the other side. Similar position alterations 
are also applied to the R67/DHF/DHF complexes (R67/D5b/D5a and R67/D5a/D5b) and 
to the productive complexes with DHF started in a deeper binding position (R67/NX/D7b, 
etc). The locations of the DHF ligands in R67/D5b/D5a and R67/D5a/D5b came from the 
average structure of R67/NX/D5. The D5b ligand in the R67/D5b/D5a complex has the 
same deep binding conformation as the D5 in R67/NX/D5 while the D5a was built 
according to symmetry. The R67/D5a/D5b has a reversed re/si orientation for the DHFs 
when compared to R67/D5b/D5a. A complete list of the simulated complexes is provided 
in Table 6. All of the simulations were performed for 10 ns except R67/D4 with a 4 ns 
simulation. The R67/D4 model was not performed further because this DHF 
conformation was extremely similar to R67/D13 during the first 4 ns of simulation and 
therefore not continued. 
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* The DHF conformation of altered starting position is listed with "a" (side occupation) 
or "b" (deep occupation). 
4.2 Results and Discussion 
4.2.1 Protein backbone analysis 
The overlap of the backbones of the selected average structures showed no 
differences between various complexes, which is in accordance with the truncated ligand 
simulations (Fig. 37 in Appendix). These conserved backbone structures indicate that no 
backbone conformational change occurs upon binding of the full ligands, further supports 
the theory that the backbone structure acts as a scaffold for binding and catalysis. The 
backbone RMSD plots show that all the complexes stay relatively stable after 2ns and the 
fluctuations are of a similar size to the backbone RMSDs from the truncated ligand 
simulations (Fig. 23 and Fig. 38 in Appendix). These results indicate that the tail of the 






Fig. 23. Backbone RMSDs vs. time for most simulated complexes. The remainder is 
provided in the appendix (Fig. 38). 
4.2.2 Ligand RMSDs and Conformations 
Although the backbone RMSDs are stable and similar for all the studied 
complexes, the ligand RMSDs behave differently across the various complexes (Fig. 24 
and Fig. 39 in Appendix). The NX ligand has a low and flat ligand RMSD (2-3 A) 
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Time (ns) 
Fig. 24. Ligand RMSD plots for the simulated complexes. For the ternary complexes, 
the ligand plotted with certain color is shown in bold. The remainder of the complexes 
are displayed in Fig. 39 in Appendix. 
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The only exception is found for the NX ligand in R67/NX/D14b where a flexible 
ligand RMSD was found, especially towards the end of the simulation. Conformational 
analyses indicate that the NX ligand is stable and maintained a conserved binding site in 
all the complexes except for minor differences near the tail (Fig. 25). The tail of the NX 
ligand in the R67/NX2 and R67/NX /NX complexes has a slight bend toward the protein 
while the conformation in the X-ray structure (PDB ID: 2RK1), R67/NX/NX, and 
R67/NX/DHF has the NX tail facing toward the solvent. Although all the NX 
conformations were built from the X-ray crystal structure (PDB ID: 2RK1), the 
pyrophosphate group shifted to a new conserved position in all of them (Fig. 25). The 
NADPH conformations from the docked structures (N33 and N96) have higher ligand 
RMSDs (3-4 A) (Fig. 38 in Appendix), suggesting that they are more flexible than the 
NX conformation. Conformational analysis shows that they have undergone large 
movements away from their starting structures (Fig. 25). 
For the R67/DHF complexes, the D23, D24, and D25 ligands are very flexible 
and have high ligand RMSDs. D24, which has a ligand RMSD higher than 10 A and is 
not displayed. The rest of the docked DHF conformations D5-D22 all have low ligand 
RMSDs, while the DHFs with altered conformations (D5a, D7a, D7b, D9a, D9b, D14a, 
D14b) have much higher ligand RMSDs (Fig. 24). These results indicate that the docked 
DHF conformations are less flexible than the altered conformations when compared with 
their corresponding starting structures. 
The pteridine ring of the DHF ligand has three possible binding positions (side, 
center, and deep), DHFs started from a deep binding position can move to a centered 
binding position (e.g. R67/D7b, R67/D9b, and R67/D14b) and centered binding positions 
can shift to a side-occupation binding (e.g. R67/D5, R67/D19, R67/D22, R67/D23, 
R67/D24, R67/D25, R67/D7/D7, R67/D19/D19, R67/D5/D7, R67/D5/D14, R67/D7/D14, 
and R67/NX/D7) (Fig. 26). 
The ligand in bold refers to the active ligand in the ternary complex under description. 
77 
Fig. 25. Overlap of the average structures containing NADPH. a) R67/N33 (red), 
R67/N96 (green), and R67/N96/D5 (blue and yellow). The starting structures for 
R67/N33 and R67/N96 are displayed as line representations, b) X-ray (PDB ID: 2RK1) 
(red), R67/NX (yellow), R67/NX2 (green), and R67/NX/NX (blue and orange), c) 
R67/NX/D5 (red), R67/NX/D7b (yellow), R67/NX/D9b (green), and R67/NX/D14b 
(blue). The Q67 residues are displayed in cyan and K32 residues in purple. 
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Fig. 26, Overlap of the average structures containing DHF. a) R67/D5 (red), R67/D5a 
(yellow), R67/D5b (green), R67/NX/D5 (blue), and R67/D5/D5 (orange), b) R67/D7 
(red), R67/D7a (yellow), R67/D7b (green), R67/NX/D7b (blue), and R67/D7/D7 
(orange), c) R67/D9 (red), R67/D9a (yellow), R67/D9b (green), R67/NX/D9b (blue), and 
R67/D9/D9 (orange). The Q67 residues are displayed in cyan and the K32s in purple. 
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Fig. 26 (Continued). Overlap of the average structures containing DHF. d) R67/D14 
(red), R67/D14a (yellow), R67/D14b (green), R67/NX/D14b (blue), and R67/D14/D14 
(orange), e) R67/D13 (red), R67/D19 (yellow), R67/D22 (green), R67/D23 (blue), 
R67/D24 (orange), and R67/D25 (gray). The Q67 residues are displayed in cyan and the 
K32 residues in purple. 
For these R67/DHF/DHF complexes, since one (or both) of the DHF ligands 
moved away from the center, the stacking effect between ligands is lost. The DHF ligands 
in the R67/DHF complexes that started from a side-occupation site (R67/D5a, etc) still 
remained on the side. Thus, the reverse motion from side to center was not seen and the 
motion from center to deep is rarely observed (R67/NX/D5, R67/D7/D9, and 
R67/D5/D9). Since movement to a deeper binding position was observed for both the 
tDHF/tDHF and NR/tDHF truncated ligand complexes, the tail seems to create a much 
higher barrier to movement deeper into the active site. 
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Fig. 27. Overlap of the DHF ligands in the R67/DHF/DHF average structures. The 
first DHF ligand is shown on the left and second DHF on the right, a) R67/D5/D5 (red), 
R67/D9/D9 (yellow), R67/D13/D13 (green), R67/D14/D14 (blue), and R67/D9/D14 
(orange), b) R67/D5a/D5b (red), and R67/D5b/D5a (yellow), R67/D5/D9 (green), and 
R67/D7/D9 (blue), c) R67/D5/D7 (red), R67/D5/D14 (yellow), R67/D7/D7 (green), 
R67/D7/D14 (blue), and R67/D19/D19 (orange). The Q67 residues are displayed in cyan 
and the K32 residues in purple. 
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For the remaining R67/DHF/DHF complexes (R67/D5/D5, R67/D9/D9, 
R67/D13/D13, R67/D14/D14, and R67/D9/D14), the pteridine rings of both DHFs 
remained in the center of the active site and were stacked over each other (Fig. 27). The 
second DHF in R67/D5/D5 adopted a new conformation and thus has a higher ligand 
RMSD. In R67/D9/D9, both DHFs remained similar to their starting structure and have a 
low ligand RMSD. In R67/D13/D13, both DHFs are in a similar conformation and the 
pteridine ring has rotated 90° to give vertical overlap between the rings rather than the 
horizontal overlap found in the other R67/DHF/DHF complexes. Also, the second DHF is 
flexible and has a high ligand RMSD. Although both D13 ligands have similar 
conformations in the average structure, the tail of the second D13 goes through several 
conformational changes during the simulation. The DHFs in R67/D14/D14 and 
R67/D9/D14 all exhibit relatively low and flat ligand RMSDs, indicating their low 
fluctuations. In these complexes, both D9 and D14 have conserved conformations which 
are different from each other. 
After the simulations, the average structures showed that for some of the 
complexes, the DHF tail conformations had moved away from their starting structure, 
indicating the flexibility of the tail (Fig. 26). The pteridine ring area also sampled 
alternate conformations. In the R67/19, R67/D22, and R67/D25, R67/D5/D14, 
R67/D7/D7, R67/D13/D13, and R67/D19/D19 complexes, the ring area can adopt a 
perpendicular conformation compared to the starting structure, suggesting that the ring is 
flexible as well. These observations disagree with the theory that the tail may prevent the 
ring fluctuations observed in the truncated simulations. This data provides further proof 
that the conformations for the truncated ligands are reasonable and that their binding 
energies are relevant. 
For the productive complexes, the R67/N96/DHF complexes have large hydride 
transfer distances (5.08-6.22 A). In the R67/NX/DHF complexes, reasonable hydride 
distances are found for the R67/NX/D5 (2.96 A), R67/NX/D7b (3.17 A), R67/NXD9b 
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(3.24 A), and R67/NX/D14b (3.03A) complexes. Among them, the DHF ligand in 
R67/NX/D5 was able to move into the NADPH side to form a stacking interaction with 
the nicotinamide ring while the other three DHFs (D7b, D9b, and D14b) were started 
from a deep binding site and the stacking with NADPH was remained. This changing of 
DHFs' binding site resulted in an initial increase in their ligand RMSDs, but the RMSDs 
flatten out, suggesting that the new conformations are stable. The DHFs in R67/NX/D9 
(4.56 A) and R67/NX/D14 (4.71 A) remained in the center and thus have large hydride 
transfer distances. The DHF in the R67/NX/D7 complex moved out of the center of the 
o 
active site away from the NADPH, making hydride transfer unfeasible (17.1 A). These 
results contrast with the previous study using truncated ligands, where the truncated DHF, 
FOL, DHFH+ were started from the center of the active site and successfully moved to 
the truncated NADPH (NR) side for hydride transfer. Therefore, the tail of the DHF 
ligand most likely increased the barrier for deeper binding as mentioned previously. 
Structural analysis showed that these productive complexes (R67/NX/D5, R67/NX/D7b, 
R67/NX/D9b, and R67/NX/D14b) have distinct DHF tail conformations, which spread 
from the ceiling to the floor. The various possible tail confirmations for the DHF ligand 
may well explain the invisibility of the DHF tail in the X-ray studies. 
4.2.3 Binding Energy Analysis 
The binding energies of all the simulated complexes were calculated using the 
MM-PBSA and quasi-harmonic methods (Table 7) as in the previous study. The 
R67/DHF complexes have varied binding energies ranging from -2.2 kcal/mol to -21.2 
kcal/mol. This large range is due to the various possible binding conformations of the 
DHF ligand (Fig. 26). Again, the flexibility observed for a single DHF molecule is in 
accord with its weaker binding energy. The R67/D4 and R67/D13 have similar binding 
energies (-10.7 kcal/mol vs. -11.8 kcal/mol) because of the previously mentioned 
conformational similarity of these ligands. 
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The binding energies indicated with * were found to move away from the center of the 
active site to a side-occupation site or were started on the side and remained there. 
Not surprisingly, the R67/DHF complexes with the ligand occupying the side of 
the active site generally have weaker binding energies than the DHFs that occupy the 
center or deeper binding sites (Fig. 26). For example, R67/D5 (center) and R67/D5a (side) 
have weaker binding energies (-11.0 kcal/mol and -2.8 kcal/mol) than R67/D5b (deep, 
-18.3 kcal/mol). The R67/D7a (side) has a weaker binding energy (-4.0 kcal/mol) than 
R67/D7 (center, -5.7 kcal/mol) and R67/D7b (deep, -7.9 kcal/mol). Similar patterns can 
be found for the binary complexes involving D14, D14a, and D14b. Also, the 
R67/D19-25 complexes, in which the DHF ligand has moved off to the side, have binding 
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energies in the lower end range (-2.2 kcal/mol to -10.3 kcal/mol). The only exception is 
for the R67/D9a complex, which has a higher binding energy (-21.2 kcal/mol) than 
R67/D9 (center, -16.4 kcal/mol) and R67/D9b (deep, -11.5 kcal/mol) despite its side 
occupation. The high binding energy of R67/D9a shows that side occupation is not 
necessarily associated with unfavorable binding. Instead, the D9 tail conformation is 
thought to be a favored geometry. The binding energies of the binary complexes with a 
D9 conformation are higher than the binding energies for all but two of the other binary 
complexes. These results suggest that the tail conformation of DHF has a significant 
effect on the calculated binding energy. 
In the R67/DHF/DHF complexes formed using the docked structures, the 
pteridine rings of the two DHF ligands in R67/D7/D7, R67/D19/D19, R67/D5/D7, 
R67/D5/D14, R67/D7/D9 and R67/D7/D14 were no longer stacked on top of each other 
(Fig. 27c). Therefore, these simulations were excluded from further analysis since they 
lack this important interaction. This decision is further supported by the weak binding 
energies for these complexes. For the remaining structures, ligand D9 continued to 
exhibite strong binding energies ranging from -15.2 to -19.9 kcal/mol for the R67/D9/D9, 
R67/D5/D9, and R67/D9/D14 complexes. The binding energy of D9 in the 
R67/DHF/DHF complexes is similar to R67/D9 (-16.4 kcal/mol), indicating that the 
stacking effect does not contribute significantly to its binding energy. However, 
7i-stacking increased the DHF binding energies in R67/D13/D13 (-15.9 kcal/mol), 
R67/D14/D14 (-16.1 and -13.2 kcal/mol), R67/D5/D9 (-16.7 kcal/mol), and R67/D9/D14 
(-15.0 kcal/mol) compared to their corresponding R67/DHF complexes. Thus positive 
cooperativity is observed for these conformations. Once a second DHF is bound, both 
DHFs bind strongly as indicated by R67/D14/D14, R67/D5/D9, and R67/D9/D14. 
The centered-symmetrical positions of the R67/D5/D5, R67/D13/D13, 
R67/D9/D9, R67/D14/D14, and R67/D9/D14 complexes result in similar binding 
energies for both DHF ligands. Similar results were also seen for the R67/tFOL/tFOL 
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study, where center-binding ligands had similar binding energies (-16.1 and -15.9 
kcal/mol) for both tFOL ligands. Only R67/D13/D13 showed significantly different 
binding energies for the two DHFs. Unlike the truncated ligands, none of the ternary 
binding energies were stronger or even as strong as the binding energy of R67/D9a. 
The actual binding of the first DHF may involve multiple tail conformations and 
initial movement deeper into the active site may be prevented by high activation barriers, 
as mentioned previously. To overcome some of these difficulties and because in the 
truncated studies the DHFs occupied one side of the pore, new models (R67/D5b/D5a, 
R67/D5a/D5b) were made from the average structure of R67/NX/D5. The binding energy 
of the D5a was larger in both ternary complexes. In addition, the D5b binding energy was 
increased in R67/D5b/D5a and is larger than the binding energies observed for the binary 
complexes. A large positive cooperativity effect was also observed. 
In the R67/N33 complex, the NADPH ligand begins moving out of the active site 
and the extremely low binding energy (-5.2 kcal/mol) demonstrates that this complex is 
not a correct representation of R67/NADPH. Thus, this complex was not used to build 
other ternary structures (Fig. 25a). Although R67/N96 and R67/NX have distinct starting 
conformations (in R67/N96, both the head and tail of the NADPH are inside the active 
site and in R67/NX, the tail extends out toward solvent), the binding energy calculation 
predicted strong binding for both N96 (-39.2 kcal/mol) and NX (-41.2 kcal/mol). 
Therefore, the R67/NADPH/NADPH and R67/NADPH/DHF models were made from 
these two NADPH conformations. However, the expected negative binding cooperativity 
was not observed for R67/N96/N96 (-22.1 and -21.5 kcal/mol) and the R67/N96/DHF 
complexes have low binding energies for both the NADPH (-15.3 to -32.6 kcal/mol) and 
DHF (0.3 to -10.7 kcal/mol) ligands. In addition, the hydride transfer distances between 
o 
NADPH and DHF are greater than 5 A. The orientation where both the head and tail are 
inside the active site appears to cause a steric effect when two N96 are bound and 
prevents the DHF ligand from stacking with the N96 nicotinamide ring in the productive 
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complexes (Fig. 25a). 
In agreement with the stability of the NX conformer, the NX ligand had strong 
binding energies in the different complexes, except in the R67/NX/NX complex where 
the second NX bound more weakly (-33.0 kcal/mol), reproducing the expected negative 
cooperativity. In addition, the first NX ligand in R67/NX/NX has a very strong binding 
energy (-55.7 kcal/mol) and different tail position than other NX ligands. Therefore, the 
conformation of the first NX in the average was taken to generate the R67/NX2 complex, 
and this binary complex exhibited the same binding conformation (Fig. 25b) and similar 
strong binding (-59.0 kcal/mol). 
The unfavorable binding energy of the DHF ligand (2.4 kcal/mol) in R67/NX/D7 
can be attributed to the lack of a stacking interaction between the NADPH and DHF 
ligands. The D7 ligand moved to a side-occupation and the pteridine ring has a 
perpendicular conformation with regard to its starting structure (image not shown). The 
DHF ligands in the R67/NX/D5, R67/NX/D9, and R67/NX/D14 complexes have higher 
binding energies than in their corresponding R67/DHF models, but only R67/NX/D5 has 
a reasonable average hydride transfer distance and complete 7t-stacking with the NX 
ligand (Fig. 25c). 
Among the productive complexes which have reasonable hydride transfer 
distances (R67/NX/D5, R67/NX/D7b, R67/NX/D9b, and R67/NX/D14b), the NX ligand 
in R67/NX/D14b has the weakest binding energy (-34.6 kcal/mol). This finding 
corresponds to the flexible NX ligand RMSD for R67/NX/D14b mentioned previously, 
indicating that the strong interactions between the NX ligand and the protein is disturbed 
in this simulation. The NX ligands in the remaining complexes have strong binding 
energies (-40.4 to -47.6 kcal/mol). The binding energies for the DHF ligands in 
R67/NX/D5, R67/NX/D7b, and R67/NX/D9b are much stronger (11.8 kcal/mol or larger) 
than in their corresponding R67/DHF complexes, which represents the positive 
cooperativity of the NADPH/DHF combination. The extremely large binding energy of 
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the DHF ligand in R67/NX/D9b (-35.5 kcal.mol) further proves the favorability of this 
tail conformation. The binding energy for the DHF ligand in the R67/NX/D14b complex 
was only -0.5 kcal/mol. This observation suggests that the hydride transfer does not 
necessarily occur with a strongly bound DHF and the actual binding of DHF may involve 
multiple tail conformations. Positive binding cooperativity for NADPH/DHF was 
achieved for the majority of the DHF conformations. 
4.2.4 N5 protonation 
The possible protonation of the DHF's N5 position by solvent was also studied for 
the productive complexes. A cutoff distance of 2 A was used to calculate the hydrogen 
atoms from the solvent which are close enough to protonate the N5 atom on DHF. Results 
showed that, for the R67/NX/D5 complex, hydrogen atoms from the surrounding water 
molecules are within the protonation distance 12.7% of the simulation time. Complexes 
of R67/NX/D7b, R67/NX/D9b, and R67/NX/D14b have percentages of 12.8%, 11.8%, 
and 5.1% respectively. While these percentages are low, the possibility of water 
protonation to the N5 position during catalysis is still possible. The percentages are lower 
than for the truncated complex R67/NR/tDHF (33.3%), because the ligand tails reduce 
the number of water molecules inside the active site. The tail of the DHF ligand in the 
R67/NX/D14b complex is right in the middle of the active site, which further prevents 
water from entering the active site. If the possibility of protonation is calculated between 
the solvent oxygen atom and the N5 atom of the DHF ligand with a 3 A cutoff distance, 
R67/NX/D14b has a percentage of 14.1% and the other three productive complexes have 
percentages of 32% or higher. 
4.2.5 Side Chain Contacts 
Differences in the side chain contacts between the protein and the ligands can also 
indicate differences in the ligand binding positions. A cutoff distance of 4 A was used to 
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determine these contacts (Table 8). Results show that the NADPH ligand has more 
contacts than the DHF ligand because of its greater size and more stable conformation. 
Since full ligands are used and the number of contacts has drastically increased, only the 
key residues (K32, Q67, 168, and Y69) are listed for clarity. Structures with unstable 
binding energies or unreasonable conformations are excluded from this analysis. 
For the DHF binary complexes, the interactions with important residues varied 
greatly. Again, this further supports the lack of a consensus binding site and low binding 
energy of DHF. In general, and not surprisingly, ligands with more residue contacts, such 
as R67/D5, R67/D9, R67/D5b, R67/D7b, and R67/D9b have higher binding energies. The 
only exception is found for R67/D9a, where only two important residues were located. 
Yet, this DHF has the highest binding energy among all DHF binary complexes. A closer 
look at this structure shows that the D9a is surrounded by a series of residues in which 
only a few atoms from each residue are within the 4 A cutoff and thus don't show up in 
the contact list. R67/D14a lost its ionic interaction with the K32 residue and thus, has a 
low binding energy. Although R67/D5a has six residue contacts, the ring area of D5a is 
bent inside the active site and is therefore not favored. During the simulation, the D7 and 
D14 ligands tended to move toward the D9 conformation. The average structures and 
residue contacts show that these DHF ligands are very close and have similar residue 
interactions, further supporting the theory that the D9 conformation is a more stable 
conformation. The stable binding of D9 is further evidenced in the R67/D9/D9, 
R67D5/D9, R67/D7/D9, and R67/D9/D14 complexes where D9 maintains a conserved 
series of residue contacts. 
For the NX ligand, the residue contacts are conserved through the many different 
complexes and NX has contacts with both K32 residues on its edge of the active site. The 
NX ligand in the R67/NX/D7b complex only interacts with one K32 residue but still has 
a high binding energy, suggesting that the second K32 residue has only a small effect on 
NADPH binding. The contacts for the DHF ligand in the productive complexes differ 
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considerably. The loss of the K32 interaction in R67/NX/D14b gives this DHF ligand an 
extremely low binding energy of -0.5 kcal/mol. Thus, the ionic interaction between K32 
and the DHF tail plays an important role in DHF binding. 













67, 68, 167, 168, 169,232, 267 















732, 167, 268, 367, 368 
», 167, 268, 368 
J, 168,232,267,268,369 
68, 167, 168, 268, 269,332, 367 
67, 68, 69, 267,332, 368 
Residue Contacts (Ligand I) 
68, 167,232,268,269,367 
68, 732, 167, 268, 367, 368 
732, 167, 268, 367, 368 
68, 732, 167, 168, 367, 368, 369 
732, 167, 268, 367, 368, 369 
732, 167, 268, 367, 368 
32, 67, 68, 69, 267,332, 368 
32, 67, 68, 69, 267,332, 368 
32, 67, 68, 69, 267, 368 
32, 67, 68, 69, 267,332, 368 
32, 67, 68, 69, 267, 332, 368 
Complex Residue Contacts 
R67/D7a 732, 169, 268 
R67/D7b 32, 67, 267, 268, 367, 368 
R67/D9a 732, 167 
R67/D9b 32, 67, 267, 268, 269, 367, 368 
R67/D14a 67, 167, 168, 269 
R67/D14b 32, 67, 267, 368 
Residue Contacts (Ligand II) 
67,68,69, 168,267,332 
32, 67, 68, 168, 267, 368 
32, 67, 267, 268, 368 
32, 67, 68, 168, 267, 368 
32, 67, 267, 268, 269, 368 
67, 267, 268, 269,332, 368 
732, 167, 168, 169,232, 268, 367 
167,168,232,367,368,369 
732, 167, 168, 169, 367, 368, 369 
732, 167, 169, 367, 368 
68, 167, 168, 367, 368, 369 
Ligand I refers to the first appeared ligand in the ternary complex and ligand II refers to 
the second appeared ligand in the ternary complex. Residue K32s are displayed in bold 
italics. 
4.2.6 Hydrogen Bonding Analysis 
Hydrogen bonds between the ligand and the protein are calculated from the 
o 
average structures with a cutoff distance of 2.5 A (Table 9). For complexes containing the 
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NX ligand, the hydrogen bonds to the NX ligand are conserved, yet again indicating the 
well-maintained NX conformation through different complexes. 








































'* 136, 167*, 368* 
•*, 251 
', 36, 67, 268* 
'*, 136, 167*, 368 
i, 151,167,232* 236, 367 
,,151,232,236,267,367* 
H-bonds (Ligand I) 
151, 166,232*, 236 
732* 136, 368 






132*, 167, 168, 366, 367 
32*, 36, 67, 68*, 266, 332 
32*, 36, 67, 68*, 266*, 332*, 334 
32*, 36, 67, 68*, 266*, 332*, 334, 
32*, 36, 68*, 264, 266*, 332 
32, 36, 67, 68*, 69, 266* 
32, 36, 67, 68*, 266*, 332, 334 






67*, 732* 136, 368 
732* 136, 167, 251, 364, 365, 366 
32*, 36, 67*, 268* 
732* 136,167,251,366 
R67/D14a 66, 167 





732* 136, 246 
732 
67, 151,232* 236,366, 367 
H-bonds (Ligand II) 
none 
32* 36, 66*, 68, 267*, 351 
32, 66, 167*, 367 
32*, 36, 268* 
268*, 332 
32*, 36, 66*, 68, 267* 
32*, 268*, 332* 
32*, 267 
46, 51, 268*, 332* 336 
--
--
732, 136, 167, 168*, 232* 366*, 367 
146, 151,232* 236,368* 
732* 368* 
732* 136, 169*, 368* 
167, 267, 368* 
Residues indicated with * have two hydrogen bonds to the ligands while the rest has one 
hydrogen bond to the ligand. Residues K32s are displayed in bold italics. 
91 
The tail of the NADPH ligand only adds a few new hydrogen bonds when 
compared to the truncated NADPH (NR), since the tail extends toward the outside of the 
active pore. In addition, the binding energy is only slightly higher than for the truncated 
NADPH. In the R67/NX/NX complex, the ring areas of both NADPH ligands occupy the 
center and have symmetric hydrogen bonding patterns between ligand and protein. 
However, the tail of the first NADPH is closer to the protein than the second NADPH, 
which could be the reason for the differences in their binding energies In addition, the 
protein Q67 hydrogen bonding network is not established on the side containing the 
second NADPH ligand, which could contribute to the weaker binding of this ligand. 
When comparing the NADPH tail interactions to the protein, both R67/NX2 and 
R67/NX/NX have two hydrogen bonds to K332 and interact with S334, while these 
interactions are longer or not observed in other complexes containing NADPH. This 
difference originates from the different tail positions found in the average structures and 
is strongly related with the binding energy. 
The DHF ligands in the productive complexes have varied hydrogen bonding 
patterns because of their differently oriented tails. In the R67/NX/D5 and R67/NX/D9b 
complexes, there are more hydrogen bonds between the DHF ligand and the protein than 
for the R67/NX/D7b and R67/NX/D14b complexes and therefore the first two productive 
complexes have higher binding energies (-23.5 and -35.5 kcal/mol) than the latter two 
(-17.5 and -0.5 kcal/mol) . In particular, in the R67/NX/D14b complex, the hydrogen 
bond from DHF to the lysine residue is missing, which significantly reduces the binding 
energy. For the R67/DHF and R67/DHF/DHF complexes, the hydrogen bonds between 
the protein and the ligand are also diverse. This is not surprising because of the different 
tail conformations of the DHF ligands. The R67/D9a complex has more hydrogen bonds 
between the DHF and the protein than in the R67/D9 and R67/D9b complexes, 
explaining the high binding energy for the D9a even though it occupies the side of the 
active pore. 
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In other complexes containing DHF, residue K32 again exhibited its strong effect 
on the binding energies. In the R67/D7a and R67/D14a complexes, the DHF ligands have 
low binding energies because of their total loss of contact to K32. In the complexes 
R67/D5a, R67/D22, and R67/D24, the DHF ligands have only one hydrogen bond to the 
K32 residue and exhibit low binding energies. In the R67/D5/D5 and R67/D13/D13 
ternary complexes, the bolded DHFs are missing one hydrogen bond to the K32 residue 
compared to the other ligand and thus have lower binding energies. All the DHF ligands 
with strong binding energies have two or more hydrogen bonds to a K32 residue, which 
implies these DHFs will have better ionic interactions with K32 and thus have higher 
binding energies. Many DHFs with low binding energies have only one or no hydrogen 
bond to the K32 residue, indicating a weaker or no ionic interaction with the K32 residue. 
In the docking studies of the productive complex, the folate conformation with the 
highest score was predicted to form a hydrogen bond between the hydroxyl group of Y69 
and the a-carboxylate of the folate tail. Other high scoring conformers predicted multiple 
tail positions of DHF which lacked this hydrogen bond. Also, the X-ray crystallography 
and NMR studies show a disordered tail region.18'21 Therefore, the interactions between 
Y69 and folate (or DHF) are weak and/or transient.47 Similar observations are also seen 
in the simulated complexes containing DHF, where only R67/D7a and R67/NX/D9b 
complexes have DHF hydrogen bonded to the Y69 residue among all 38 DHF 
conformations. 
4.2.7 Binding Energy Decomposition 
The binding energy decomposition is calculated using the MM-GBSA method 
(Table 10-12). It is obvious that the K32 residues have the largest contribution to the 
ligand binding energy; therefore, losing the interaction with K32 will significantly reduce 
the ligand binding energy. This result is in accordance with hydrogen bond analyses 
where ligands with low binding energies have less or no hydrogen bonds to the K32 
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residues. Other residues, which have a hydrogen bond to the ligand, also have a high 
contribution to the binding energy, e.g. A36, V66, Q67, and 168. 






























































































































































































Residue contributions from K32, Q67, 168, Y69 and counterparts are displayed in bold. 
The unusual strong or weak energy contributions are listed in bold italics. 
The binding energy contribution can be broken down into backbone and side 
chain contributions. For the complexes containing NADPH, the backbone contributions 
are similar for the NADPH ligand across different complexes except for residues S334, 
G335, and A336, which are located at the edge of the active site and thus have slightly 
different interactions with the NADPH depending on its tail conformation. These three 
resides are related to the strong binding of NADPH in the R67/NX2 and R67/NX/NX 
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complexes as high contributions from these residues are observed. The NADPH ligand in 
these two complexes has the tail bent toward these residues, and thus has a higher binding 
energy through hydrophobic interactions. 




































































































Major backbone contributions from the important residues are displayed in bold. 































































































































Residue K32, Q67,168, Y69 and counterparts are displayed in bold. The unusual strong 
or weak energy contributions are listed in bold italics. 
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K32 and K33 are the only two charged residues in each monomer located near the 
pore.37 Mutations at K32 affected the quaternary structure and produced inactive dimers. 
The K33M mutant shows only 2-4 fold effect on Km values. The fluorescence quenching 
and ITC studies suggest that two ionic interactions are involved in binding the first 
NADPH ligand and both ionic interactions are likely to be involved with the K32 residue 
rather than the K33 residue.37 This hypothesis is based on the crystal structure in which 
K32 on the binding surface of the active site pore has direct interaction with NADPH. A 
similar interaction for K33 was not observed.18 The docking studies also revealed that 
K32 residues are involved in binding both NADPH and DHF ligands, while no direct 
interactions are found for K33. Furthermore, the K33M mutants have only a minor salt 
effect, indicating that only K32 is involved in the ionic interaction. In addition, the two 
ionic interactions come from K32 residues on different monomers, one K32 (monomer A) 
would interact with the 2'-phosphate and the other K32 (monomer D) would interact with 
the pyrophosphate bridge.13'37 
From the simulation results, the hydrogen bond list shows that there is no direct 
hydrogen bond interaction between NADPH and the K33 residue. The residue contacts 
also show no interactions with the K33 residue, which match with experimental 
observations. However, K33 is conserved in all R-plasmid encoded variants, indicating 
its importance. Although the role of K33 is not clear, its functional role may involve 
properly positioning K32 for interaction with the ligands and may contribute to the 
positive electrostatic potential at the active site pore.13'104 This importance can be seen in 
the residue binding energy decomposition where both K33 (-0.57 to -0.63 kcal/mol) and 
K333 (-0.76 to -1.80 kcal/mol) contribute to the binding energy of the NADPH ligand. 
The K32 residue is also conserved in all R-plasmid encoded variants suggesting 
its functional and structural role.105 The DELPHI and docking studies predict that K32 
residues have a positive electrostatic potential which is attractive to the negatively 
charged ligands.13 Salt effect studies indicated that K32 is important in both binding and 
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catalysis. From the binding energy decomposition, K32 contributes the most to the 
NADPH binding energy. In complexes involving the NADPH ligand, hydrogen bonds 
can be found from K32 and K332 to NADPH, which matches with the two predicted 
ionic interactions. Although there are no direct hydrogen bonds to K332 in the 
R67/NX/D7b and R67/NX/D14b complexes, the hydrogen bonds are calculated from the 
average structures and a hydrogen bond could exist during part of the simulation. The 
residue contacts show a K332 interaction with the NADPH in R67/NX/D14b but not in 
R67/NX/D7b. This lack of an interaction with K332 is displayed in the binding energy 
decomposition where K332 only contributes -0.44 kcal/mol to the NADPH binding 
energy in R67/NX/D7b, which is much less than for the other complexes. 
As mentioned previously, docking studies suggest that Y69 and symmetric 
counterparts may interact with both NADPH and DHF ligands.13 The Y69F mutant 
displays 22-fold weaker binding to NADPH when compared to wild type R67 DHFR.40 
NMR studies show that the Y69 residue undergoes chemical shifts upon NADP+ binding, 
indicating the Y69 residue may be involved in binding the NADPH ligand. The I68L 
and I68M mutations weakened the binding to NADPH by 7-9 fold.40 The importance of 
these two residues can be seen from the binding energy decomposition where Y69 
generally has a contribution near 2 kcal/mol for the NADPH ligand and 168 has a 
contribution of over 1.5 kcal/mol. 
For the DHF ligand, the distance between the carboxylate groups on the Glu tail is 
short and the two groups cannot span across the active site to interact with both K32 
residues, suggesting that only one ionic interaction will occur for the DHF ligand. 7 The 
hydrogen bond list (Table 9) shows that there is a maximum of one K32 residue 
interaction though two hydrogen bonds are often formed to this residue. Due to the 
flexibility of the DHF tail, there are also complexes in which the DHF ligand is missing 
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The tail flexibility for the DHF ligand was seen from the X-ray crystal structures 
1-3 10 01 
and docking studies. ' ' But such flexibility does not introduce energy contribution 
from a wide range of residues. On the contrary, the decomposition of the residue 
contribution to the DHF binding energy indicates that major contributions are made from 
residues K32, G35, A36, Q67, 168, Y69 and corresponding counterparts (Table 13). The 
K32 residue contributes the most toward the DHF binding energy and the loss of contact 
or weak interaction to the K32 residue will result in low binding energies for the DHF 
ligand (e.g. R67/D5/D5, R67/NX/D7b, and R67/NX/D14b), suggesting the ionic 
interaction between K32 and the DHF tail is important for the strong binding of the DHF 
ligand. 
Residues G35 and A3 6 contribute to the DHF binding energy through their 
backbone (Table 13, 14) since glycine has no side chain and alanine only has a methyl 
group as the side chain. Residues Q67, 168, Y69, and P70 have their side chains facing 
inside the active pore and have close contacts with DHF, and thus, have large 
contributions to the DHF binding energies. Y69 and P70 are closer to the edge of the 
active site compared to Q67 and 168, and therefore backbone contributions are not 
observed for residues Y69 and P70. A similar pattern is observed for residue K32, where 
only the side chain is involved in DHF binding. A contribution from another key residue, 
V66, is not observed for the DHF binding energy. V66 is buried deeper than the other key 
residues and the DHF ligand is not able to form as close an interaction as NADPH. 
4.3 Conclusions 
Although docking studies predicted a single DHF ligand to be in the center of the 
active site and binding energy calculations indicated strong binding of DHF in the center 
or deeper, it is not clear whether the DHF can reach the center and deeper sites with ease. 
The first DHF may occupy either the side or center position with multiple possible tail 
positions. The complexes R67/D9/D9, R67/D14/D14, and R67/D9/D14 have DHF 
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ligands occupying the center and have higher binding energies than the corresponding 
R67/DHF complexes, reproducing the positive binding cooperativity. The low binding 
energies in R67/D5/D5 and R67/D13/D13 are associated with their flexible tail. 
Complexes of R67/D5a/D5b and R67/D5b/D5a have the ligands in side/deep binding 
positions and positive binding cooperativity is also observed for them. In the productive 
complexes R67/NX/D5, R67/NX/D7b, R67/NX/D9b, and R67/NX/D14b, the DHF 
ligands all moved into or remained in the deep binding position, which is required for 
appropriate alignment for the hydride transfer. These DHF ligands have much stronger 
binding energies than in the corresponding R67/DHF complexes, representing the 
positive cooperativity for the R67/NADPH/DHF complexes. An exception is found for 
the R67/NX/D14b complex, where the D14b ligand has a low binding energy. This 
decrease is related to the loss of contacts to the important K32 residue. Other DHF 
ligands which have less or no hydrogen bonds to the K32 residues are also found to have 
low binding energies, indicating residue K32 plays an important role in stabilizing the 
DHF ligand. 
The interaction between the K32 residue and the NADPH ligand is less profound 
than for the DHF ligand. In the complexes containing NX, the ligand with less K32 
interactions may still have a high binding energy due to the energy contribution from 
other residues such as Y69. In addition, the increased number of hydrogen bonds for the 
NX ligand causes it to have a higher binding energy in the different complexes. Also, a 
new NADPH tail conformation (bent toward protein) was observed, which had a stronger 





Experimental mutational studies are able to differentiate the importance of 
individual residues. Mutations on residue Q67 have large and complicated effects upon 
ligand binding and cooperativity. As mentioned previously, the quadruple Q67H mutation 
study showed 100 times tighter binding for both NADPH and DHF when compared to the 
wild-type R67 DHFR and Q67H asymmetric mutations exhibited various effects upon 
ligand binding.41'46 In the R67/NADPH/NADPH:A single-site mutation and two-site 
mutations of R67/NADPH/NADPH:A+D (mutations on monomer A and D), the negative 
binding cooperativity for the NADPH ligand remained while R67/NADPH/NADPH:A+B 
has a weakened negative binding cooperativity and R67/NADPH/NADPH:A+C lost the 
cooperativity completely, with similar dissociation constants for both NADPHs (Table 1). 
For complexes containing DHF, a single mutation makes both DHF ligands bind more 
strongly, similar results were obtained for the R67/DHF/DHF:A+B mutation. The 
R67/DHF/DHF:A+C and R67/DHF/DHF:A+D complexes have negative binding 
cooperativities, which is reversed from the wild type protein. A closer look into these 
mutated complexes by computational methods will help explain the experimental trends 
and locate the source of cooperative binding. 
Only the Q67H mutations will be considered in this study. Both single and 
two-site Q67H mutations are examined and the corresponding effect on NADPH or DHF 
binding is analyzed. The starting conformations of the NADPH ligand were taken from 
the X-ray crystal structures of R67 DHFR containing NADP+/DHF (PDB ID: 2RK1)22 
and the Q67H quadruple mutant with bound NADP+ (PDB ID: 2P4T).99 Since a bent tail 
conformation of NADPH (NX) was observed in the full ligand study and associated with 
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stronger binding energy, this conformation is also included (R67/NX2:A). Since only a 
truncated NADP+ is resolved in the mutant crystal structure (PDB ID: 2P4T), the 
truncated NADP+ was converted into a truncated NADPH (NR) using the CHARMM 
built-in function. Conformations for the DHF ligand are taken from the same docked 
structures as in the full ligand studies (D5, D9, D5a, and D5b).13 The R67/DHF/DHF 
two-site mutations were generated on the basis of the R67/D5a/D5b complex. The 
mutants of productive complexes are also examined based on the structure of R67/NX/D5. 
For all the selected structures (Table 16), the mutation of Q67 to histidine is performed in 
the SYBYL program.106 After the initial system setup, the same minimization, solvation, 
and equilibration processes are performed and followed by a 10 ns dynamics simulation. 




















































Theoretically, the two-site mutation has symmetry related patterns. For example, 
the vertical mutation R67:A+B is symmetric to R67:C+D, the horizontal mutation 
R67:A+C is symmetric to R67:B+D, and the diagonal mutation R67:A+D is symmetric to 
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R67:B+C. In the experimental mutational study, the ligand(s) will assume a favored 
binding conformation, therefore, the A+B mutation is equivalent to the C+D mutation in 
experiments. But this equivalency is not necessarily true in the computational study, 
where the ligand in a pre-determined position will have different interactions with the 
A+B mutant and C+D mutant. Therefore, all six possible combinations are included in 
the computational studies. Similarly, one-site mutations on different monomer are all 
equivalent in the experimental study, but the simulations have to include all four possible 
mutations (R67:A, R67:B, etc) to find the most probable binding conformation. 
Exceptions were made for the mutated R67/NR and R67/NR/NR complexes, since the 
NR conformation comes from the Q67H quadruple mutated crystal structure (PDB ID: 
2P4T) and the Q67H residue is overlapped with the B-face of the nicotinamide." 
5.2 Results and Discussion 
5.2.1 Conformational Analysis 
After the simulations, the backbone structures are examined and the overlap of the 
average structures shows that the backbone is unchanged for all the simulated mutants 
(image not shown), as was seen for the structures involving the truncated ligands and full 
ligands. The conserved backbone shows that R67 DHFR is a rigid molecule and the 
mutational effects are not achieved through backbone conformational changes. Instead, 
other factors such as interactions with Q67H may account for the various effects observed 
in the experimental studies. 
In the mutants containing NADPH, the NR ligand displays larger movements 
while the NX ligand has a more conserved conformation (Fig. 28). The NR ligand in 
R67/NR:A moved to a more centered position while the Q67H residue remain unchanged. 
Therefore, the initial stacking between the nicotinamide ring and histidine ring is lost. 
This large movement is different from the truncated ligand studies where the NR ligand 
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stayed in the same conserved site for all the simulated complexes. In R67/NR/NR:A, the 
two NR ligands have an initial overlap between each other since the NR ligand is in a 
deeper position, as predicted from the X-ray crystal structure (PDB ID: 2P4T). However, 
the average structure showed that the ring overlap is disrupted during the simulation, 
indicating that the nicotinamide rings repulse each other rather than forming strong 
inter-ligand interactions. This result suggests that no interactions between the 
nicotinamide rings from two NADPHs are tolerated and accounts for their negative 
binding cooperativity. 
Fig. 28. The starting structure (green) and average structure (blue) of a) R67/NR:A 
and b) R67/NR/NR:A. Q67H in red is the starting conformation while yellow represents 
its average conformation. 
The NX ligand displays more conformational stability through the different 
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complexes, with the exception of the ligand tail (Fig. 29). In the R67/NX2:A, the bent 
conformation of the ligand tail remained during the simulation. In addition, the NX 
ligands in R67/NX/NX:C, R67/NX/NX:A+D, and R67/NX/NX:B+C moved to a bent 
conformation as well. Ring conformational changes were observed in R67/NX/NX:B, 
R67/NX/NX:A+B, R67/NX/NX:A+D, and R67/NX/NX:B+D. These movements all 
occurred on the side with the Q67H mutation, indicating that stacking with the histidine 
ring may not necessarily be a stabilizing interaction. 
Fig. 29. Overlap of the average structures containing NADPH. a) R67/NX:A (red), 
R67/NX:B (yellow), R67/NX:C (green), R67/NX:D (blue), and R67/NX2:A (orange), b) 
R67/NX/NX:A (red), R67/NX/NX:B (yellow), R67/NX/NX:C (green), and 
R67/NX/NX:D (blue). The first NADPH ligand is shown on the right while the second 
NADPH is on the left. The K32 (purple) and Q67 (cyan) residues are displayed for better 
visualization of the active site. 
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Fig. 29 (Continued). Overlap of average structures containing NADPH. The first 
NADPH ligand is shown on the right while the second NADPH is on the left, c) 
R67/NX/NX:A+B (red), R67/NX/NX:A+C (green), and R67/NX/NX:A+D (blue), d) 
R67/NX/NX:B+C (red), R67/NX/NX:B+D (green), and R67/NX/NX:C+D (blue). 
5.2.2 Binding Energy Analysis 
The ligand binding free energies were calculated using the MM-PBSA and 
quasi-harmonic methods mentioned previously (Table 17). According to the dissociation 
constants (Kd) from experimental mutational studies (Table 1), Quad3, the unmutated 
tetramer, has dissociation constants of 4.0 (KM) and 37.1 (Kd2) uM for the first and 
second NADPH ligand respectively. In the single Q67H mutant, K&\ is slightly lower (3.6 
uM) and A^ is higher (53.5 uM) than in the Quad3 model, indicating that binding 
cooperativity is preserved. This very slight increase in binding for the first NADPH is too 
small to reasonably duplicate with our level of theory. The decrease may be large enough 
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to be observable in our simulations. For the one-site mutants, R67/NX:A, R67/NX:B, and 
R67/NX:D have comparable binding energies (-34.2 ~ -37.7 kcal/mol) to the full ligand 
study (R67/NX, -41.2 kcal/mol). The NADPH tail with bent conformation (R67/NX2:A) 
has a stronger binding energy (-48.0 kcal/mol) than other positions and this type of bent 
conformation associated with strong binding energy is also observed in the full ligand 
studies. 
Fig. 30. The average structures of a) R67/NX:A and b) R67/NX/NX:A. The first 
NADPH ligand (right) is displayed in orange with both licorice and surface 
representation while the second NADPH (left) is shown in purple. Residues Q67H, Q167, 
Q267, and Q367 are displayed in red, yellow, green, and blue respectively. 
The histidine residue side chain is an imidazole ring, which may form a 7i-ring 
stacking interaction with the pteridine ring of DHF and the nicotinamide ring of NADPH 
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or NADPy7"109 The X-ray structure (PDB ID: 2P4T) also shows that the side chain of 
Q67H stacked on the B-face of the NADP+ nicotinamide ring." In the simulations, 
conformational analyses showed that the conformation of the NADPH ligand in the 
R67/NX:A-D mutants is conserved and the side chain of the Q67H residue is parallel 
with the nicotinamide ring of NADPH in R67/NX:A (Fig. 30a). Due to symmetry, the 
Q67H mutation in R67/NX:B-D is not able to form a 7i-stacking interaction with the 
NADPH ligand and these complexes have lower binding energies. Even in R67/NX:A, 
the stacking effect is not significant and is only partial. This result differs from the 
R67/NR:A simulation, where the nicotinamide ring binds more towards the center of the 
active site and has a better stacking interaction with the Q67H residue (Fig. 3Id). 
In the R67/NX/NX two-site mutants, the NX ligands occupying the non-mutated 
side (R67/NX/NX:A and R67/NX/NX:B) have similar or stronger binding energies (-43.7 
and -34.7 kcal/mol) compared to the R67/NX single-site mutations. The NX ligands with 
direct interactions to Q67H have weaker binding energies (-20.0 and -1.1 kcal/mol), 
indicating that the Q67H mutation has a negative effect on NADPH ligand binding. In the 
R67/NX/NX:A complex, the stacking effect between the Q67H and the first NX ligand 
(orange) is further weakened and may have even vanished (Fig. 30b). In R67/NX/NX:D, 
the first NX ligand, which occupies the same side as the Q67H mutation has a weaker 
binding energy (-29.9 kcal/mol) than the second NX (-36.9 kcal/mol). In R67/NX/NX:C, 
the second NX, which occupies the mutated side has a strong binding energy (-35.9 
kcal/mol). A similar strong binding for the first NX (-39.4 kcal/mol) is caused by the bent 
tail conformation. Otherwise, a weak binding energy would most likely be associated 
with this NX ligand. These contradictions suggest that the Q67H mutation has multiple 
effects upon NADPH binding. The negative binding cooperativity was preserved, even 
with the different binding patterns, suggesting that the binding cooperativity is unrelated 
or only slightly affected by the Q67H mutation. 
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R67/D5:A stands for the Q67H single-site mutation on the monomer A while the two-site 
mutations are named as A+B, etc. 
All the complexes containing the NR ligand have lower binding energies than in 
the wild-type enzyme. The single-site R67/NR:A mutation only has a binding energy of 
-18.6 kcal/mol, which is much lower than for wild type, despite the conformational 
overlap in the starting structure (Fig. 31c-d). The expected strong binding is not observed 
I l l 
in R67/NR/NR:A (-20.4 and -11.2 kcal/mol) or the two-site mutants (-7.8 ~ -25.0 
kcal/mol). These weak binding energies suggest that these NR conformations are not 
likely to represent the actual binding conformation. The extraordinary disagreement to 
experiment for these simulations indicates that the NR conformer taken from the 
quadruple mutational X-ray structure (PDB ID: 2P4T) is not suitable for single or 
two-site mutational studies. 
Q167 Q367 Q167 Q367 
Q167 Q67 Q167 Q67 
Fig. 31. The syn and anti conformations of NADPH. a) The syn conformation of the 
ribose ring with respect to the nicotinamide ring from the starting structure of R67/NX:A. 
The Q67(H) residues from monomer A-D are displayed in red, yellow, green, and blue 
respectively, b) Top view of the R67/NX:A starting structure, c) The anti orientation 
between nicotinamide and ribose ring in the R67/NR:A starting structure, d) Top view of 
R67/NR:A starting structure. 
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In the quadruple Q67H mutant X-ray structure (PDB ID: 2P4T), the ligand is 
truncated NADP+, while the simulations use truncated NADPH (NR) as the ligand. The 
electrostatic interactions between the protein and the ligand may be different for the 
NADP+ and NADPH ligands. Therefore, the conformation or binding site of NADP+ may 
not necessarily be the same for NADPH. Also, from a structural view, the bound NADP+ 
in the X-ray structure (PDB ID: 2P4T) has a different ring orientation (anti) from the 
01 Oft QQ 
normal syn conformation (Fig. 31). ' ' Experimental Q67H quadruple mutational 
studies show a 110-fold tighter binding to NADPH when compared to wild type R67 
DHFR, but the same Q67H mutation only displays 29-fold tighter binding for NADP+.8'41 
Although there's no crystal structure of the Q67H mutant with bound NADPH, we can 
predict that the NADPH and NADP+ occupy different binding sites or adopt different 
conformations from each other based on the experimental results and the simulations. 
Therefore, the NR conformation generated from the truncated NADP+ is not appropriate 
for the simulation. This unusual NADP+ geometry may account for its high dissociation 
constant. The low binding energies of NR also indicate the unfavorablness of the anti 
conformation inside the active pore. 
In contrast, the two-site mutation simulations, the vertical mutant 
R67/NX/NX:A+B (or C+D), horizontal mutant R67/NX/NX:A+C, and diagonal mutant 
R67/NX/NX:A+D (or B+C) all reproduced the experimental trends, indicating that the 
NADPH conformation from the X-ray crystal structure (PDB ID:2RK1) is more 
reasonable. In the R67/NX/NX:A+B complex, one NADPH ligand (purple) has a strong 
binding energy (-46.2 kcal/mol) while the other NADPH (orange) has a lower binding 
energy (-20.8 kcal/mol), which matches the experimental mutational studies where the K^ 
values of the two NADPH are 2.7 and 15.0 uM respectively. The NADPH ligand with the 
low binding energy (orange) was found to have an altered ring conformation mentioned 
previously (Fig. 32c) and accounts for its weak binding. The R67/NX/NX:C+D is not 
symmetric to R67/NX/NX:A+B with regard to ligand conformation since Q67Hs from 
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monomers A and B are on the nicotinamide side (bottom) while Q67Hs from monomers 
C and D are on the ribose side (top) (Fig. 31) and the distance between the Q67Hs and 
nicotinamide ring is larger in R67/NX/NX:C+D. Therefore, a weaker cooperativity (-22.8 
and -34.4 kcal/mol) is observed. 
Fig. 32. The average structures of R67/NADPH/NADPH two-site mutants, a) 
R67/NX/NX:A+B, b) R67/NX/NX:A+C, c) R67/NX/NX:A+D, and d) R67/NX/NX:B+C. 
Residues Q67(H)s are displayed in red, yellow, green, and blue respectively. 
For R67/NX/NX:A+C, both ligands have the same binding energy of -38.3 
kcal/mol, which is in accordance with the experimental study where the horizontal 
mutation has similar Kd values of 17.7 and 16.1 uM for both NADPH ligands. The 
binding energies of the symmetric mutant R67/NX/NX:B+D (-38.3 and -16.5 kcal/mol) 
are not of similar values, as expected and the weak binding NX is found to have an 
altered ring conformation (Fig. 32d). 
In the diagonal mutation R67/NX/NX:A+D, the experimental study predicted that 
the negative binding cooperativity is preserved with K& values of 8.7 and 51.1 uM. In the 
simulation, these two NADPHs also exhibited cooperativity with binding energies of 
-51.3 kcal/mol (purple) and -13.2 kcal/mol (orange). The weak binding NADPH (orange) 
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has its nicotinamide ring displaced by Q67H and Q367H (Fig. 32c). The symmetric 
R67/NX/NX:B+C has the nicotinamide rings of both NX ligands lined up well inside the 
active site pore but one NX ligand (orange) has a very low binding energy (-1.1 kcal/mol) 
due to the flexibility of the tail (data not shown). 
All the above results suggest that the Q67H mutations have multiple effects upon 
NADPH binding. Overlap between Q67H and the nicotinamide ring allows the NADPH 
to bind normally and have a strong binding energy, while the same Q67H may also 
introduce ring displacement, which gives a weak binding energy to the NADPH. But, 
both patterns can produce the expected binding trends. 
According to the results from the single-site mutation, R67/NX:A, the partial 
stacking between the nicotinamide and Q67H may aid in the slightly stronger binding for 
NADPH. While, in the two-site mutations, the partial stacking effect does not necessarily 
give a higher binding energy for the NADPH ligand. Binding energies for the stacked 
NADPH in R67/NX/NX:B+C (purple, -48.2 kcal/mol) and R67/NX/NX:A+B (purple, 
-46.2 kcal/mol) are lower than the unstacked NADPH in R67/NX/NX:A+D (purple, -51.3 
kcal/mol). On the contrary, the two-site Q67H mutation may impede a strong binding of 
NADPH as shown by the nicotinamide ring displacement in the R67/NX/NX:A+B, 
R67/NX/NX:A+D and R67/NX/NX:B+D complexes. The dissociation constants for 
NADPH from experimental Q67H mutational studies have an order of A+B > A > Quad3 > 
A+D > A+C, while the simulations gave relatively high binding energies in the 
R67/NX/NX:A+D (or B+C, -13.2 ~ -51.3 kcaymol) and the R67/NX/NX:A+C (or B+D, 
-16.5 ~ -38.3 kcal/mol). This disagreement suggests that NADPH may bind in an altered 
orientation in the mutant not sampled by our simulations. 
Similar trends were also seen in the mutants of the productive complexes. The 
NADPH ligands in R67/NX/D5:B and R67/NX/D5:C, which do not have a stacking 
interaction with Q67H, have higher binding energies (-46.9 and -37.0 kcal/mol) than the 
NADPHs in R67/NX/D5:A (-34.0 kcal/mol) and R67/NX/D5:D (-34.9 kcal/mol) where 
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NADPH (or DHF) and Q67H are at least partially stacked (Fig. 33). In these same 
complexes the DHFs have high binding energies (-27.2, -28.6, and -31.4 kcal/mol), 
except for R67/NX/D5:A (-13.1 kcal/mol), compared to the DHF ligand in R67/NX/D5 
(-23.5 kcal/mol). The stronger binding of DHF in the productive mutants is in accordance 
with the experimental studies where the DHF in the mutant (R67/NADP+/DHF:A, d̂(DHF) 
= 2.2 nM) has lower Kd than the wild type (R67/NADP
+/DHF, A^DHF) = 4-8 MM) and the 
Quad3 (Quad3/NADP+/DHF, £<KDHF) = 4.9 uM).46 However, mutant B has the highest 
overall binding energy and the histidine ring is not involved in any stacking interactions 
in this conformer. Also, the R67/NADP+/DHF:A+D has a lower Kd (2.0 uM) than 
R67/NADP+/DHF:A+B (4.5 uM) and R67/NADP+/DHF:A+C (4.8 ^M).46 The stacking 
of Q367H in monomer D with the pteridine ring of DHF, gives the highest binding 
energy for DHF (Fig. 33d). 
Fig. 33. The average structures of R67/NADPH/DHF single-site mutants, a) 
R67/NX/D5:A, b) R67/NX/D5:B, c) R67/NX/D5:C, and d) R67/NX/D5:D. The color 
scheme is the same as previous. 
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For DHF binary mutants, the simulation results do not match the experimental 
trend. In the single-site mutations R67/D5:A-D and R67/D9:A-D, the binding energies 
are lower than for R67/D5 and R67/D9 in the full ligand studies, which is opposite of the 
strong binding predicted by experimental mutational studies (Kdi = 0.88 uM). Also, the 
conformations of these simulated DHF ligands do not show the expected stacking 
between the pteridine ring and the Q67H residue. However, the mutation does trap the 
DHF ligand in the center of the active site in all of the eight simulated models (image not 
shown). These low binding energies indicate that DHF must be in a different 
conformation to achieve the expected strong binding. 
In the R67/DHF/DHF:A-D mutants, the binding energies of the DHFs do not 
match the experimental trend either. Strong binding is found (K<u = 0.88 uM and K^i = 
2.0 uM) for both ligands, but this is not observed for the R67/D5/D5 or R67/D5a/D5b 
mutants. The deep binding DHFs in R67/D5a/D5b:B-D have high binding energies (-18.6 
to -23.1 kcal/mol), which matches with the full ligand studies where deep binding is 
found to have a stronger binding energy than center or side binding. Since the DHFs are 
deep or on the side, the expected stacking effect between the pteridine ring and Q67H is 
not observed and the second DHF has a weak binding energy. 
In the R67/D5/D5:A-D simulations, both DHFs stay in the center and can 
possibly stack with the Q67H residue. In R67/D5/D5:A, the second DHF (purple) is 
stacked with Q67H, but this DHF has a low binding energy (-3.8 kcal/mol) (Fig. 34). In 
R67/D5/D5:C, the second DHF (purple) has a partial stacking orientation with the 
Q267H residue but this DHF is also associated with an unfavorable binding energy (2.0 
kcal/mol). The first DHFs in these two complexes do have higher binding energies (-13.4 
and -13.3 kcal/mol) which is higher than in R67/D5/D5 (-6.0 kcal/mol). The low binding 
energies in these two complexes as well as the weak binding DHF (-0.9 kcal/mol) in 
R67/D5/D5 appear to result from an altered tail conformation. In R67/D5/D5:D, the 
DHFs have similar binding energies since the two DHFs have similar conformations. In 
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R67/D5/D5:B, both DHFs have altered tail conformations and the inter-ligand stacking 
effect is lost, and therefore both DHFs have low binding energies (-0.6 and -2.2 kcal/mol), 
although the first DHF stacks with the Q167H residue. These results suggest that the 
DHF tail conformation as well as inter-ligand interactions play important roles in 
achieving strong binding in the R67/DHF/DHF:A-D mutant. 
For the two-site mutations, R67/DHF/DHF:A+B should have strong binding for 
both ligands (0.97 and 1.1 uM); but, the DHFs in the simulated complexes 
R67/D5a/D5b:A+B and R67/D5a/D5b:C+D do not. However, the binding energies are 
larger than or similar to those observed for the full ligands. The expected binding patterns 
for the other two-site mutations were also not observed, indicating that the combined 
side/deep position is not the lowest energy conformation for the two-site mutations. 
A further look into the R67/D5/D5:A-D mutants may help explain the binding 
patterns. In the R67/D5/D5 full ligand study, the DHF ligands have binding energies of 
-6.0 and -0.9 kcal/mol. For the R67/DHF/DHF:A+B mutation, both DHFs can form 
stacking interactions with the Q67H and Q167H residues and thus, can have strong 
binding. The positive effect of the Q67H can be seen from R67/D5/D5, where the first D5 
ligand overlaps with the Q67H histidine ring and has stronger binding (-13.4 kcal/mol). 
Such a positive effect from Q67H stacking with the DHF ring area was also seen in 
R67/D5/D5:C (-13.3 kcal/mol) and R67/D5/D5:D (-8.7 kcal/mol) where the binding 
energies are stronger than for the R67/D5/D5. In R67/DHF/DHF:A+D, although both 
DHFs could still stack with the Q67H and Q367H residues, these two histidine residues 
are on the same side and may form a sandwich with the first DHF, leaving the second 
DHF with a weaker binding energy (^2 = 20 uM). The unusually high K^ of 
R67/DHF/DHF:A+C may originate from significant conformational changes. Since the 
Q67Hs can have alternate conformations in the R67/NADPH/NADPH and R67/NX/D5 
mutants (Fig. 33, 34), it is not surprising that the R67/DHF/DHF:A+C complex may 
adopt conformation which significantly impede the second DHF from binding. 
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Fig. 34. The average structures R67/DHF/DHF single-site mutants, a) R67/D5/D5:A, 
b) R67/D5/D5:B, c) R67/D5/D5:C, and d) R67/D5/D5:D. Residues Q67(H) on monomer 
A, B, C, and D are displayed in red, yellow, green, and blue respectively. The first DHF 
(left) is shown in orange and second DHF (right) displayed in purple. 
5.2.3 Hydrogen Bond Analysis 
A further look into the binding site may explain the different behaviors of the 
NADPH ligands in the mutant models. The hydrogen bonds between the protein and the 
ligand are taken from the average structures using a cutoff distance of 2.5 A (Table 18). 
As in the full ligand study, the strong binding NADPHs all have conserved hydrogen 
bonds to residues K32, A36, Q67, 168, V266, Q267, and K332. In the R67/NX:A 
complex, the NADPH ligand binds strongly, because it has all the essential hydrogen 
bonds as well as additional hydrogen bonds to residues S334 and A336. The 
R67/NX:B-D mutations have fewer hydrogen bonds or the bonds are weaker, and 
therefore have lower binding energies. 
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Table 18. Hydrogen bonds between the mutated protein and the ligands 
























146, 151, 167*, 232* 235,367 
146, 151,232* 236, 267,368 
146, 151, 166, 232*, 236 
32*, 36, 67, 68*, 266*, 267,332, 334, 336 
32, 36, 67, 68*, 266*, 267,332, 334, 336 
32, 36*, 67, 68*, 266*, 332 
32*, 36, 67, 68*, 266*, 332 
32*, 36, 67, 68*, 266*, 332 
32*, 36*, 67, 264, 266*, 332 
32*, 36, 68*, 264, 266*, 332, 334 
32, 36, 68*, 266*, 332*, 334 
132, 136,232, 366* 
32, 36, 67, 68*. 266*, 267,332 
132*, 136*, 232, 267, 364, 366 
167, 168*, 366*, 232* 
32, 36, 67, 68*, 266*, 332, 336 
32, 36, 68*, 266* 
32* 36,67,68*, 266*. 332 
32*, 36, 68*, 266*, 332 
32, 36, 68*, 266*, 332 
32, 36, 68*, 266*, 334 
46,51,67,266,267,332 
46, 51,67*. 267*, 332* 335 
332* 
68, 267 
732* 136*, 167,232, 364, 366* 
732* 136, 167, 168*, 232, 366* 
732, 136, 167, 168*, 232, 366* 
732, 136*, 167, 168*, 232, 366* 
32, 36, 67, 68*, 69, 266*, 332 
132*, 136, 167, 168*, 232, 366 
32*, 36, 67,68*, 266*, 332 
32*, 36, 67, 68*, 266*, 332, 334 
732* 136,167,232,366* 
732* 136,167*, 168,232* 366* 
232, 368* 
146, 151,232* 267*, 368* 
232*, 269*, 368* 
146, 151,232* 236, 368* 
The * indicates residues which have two hydrogen bonds with the ligand. For easy 
comparison, the ligand with a higher binding energy is listed on the left and vice versa. 
In the R67/NX/NX:A, R67/NX/NX:A+B, and R67/NX/NX:A+D complexes, the 
strong binding NADPH ligands all have the conserved hydrogen bonds to the protein, 
while the weak binding NADPH ligands all lost two hydrogen bonds with the 168 residue. 
In R67/NX/NX:B+C, the weaker binding NADPH (orange) lost important hydrogen 
bonds to K132 and A136. In R67/NX/NX:A+C, the hydrogen bonds are almost identical 
which accounts for the similar binding energies. In the symmetric R67/NX/NX:B+D, the 
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weak binding NADPH (purple) lost contacts to 1168. These findings further prove the 
importance of the key residues and indicate the relationship between ligand conformation 
and binding energy. 
In the R67/DHF/DHF:A-D simulations, the hydrogen bonds are identical for the 
DHFs in R67/D5/D5:B, which have similar binding energies. Yet, the high number of 
hydrogen bonds did not yield a strong binding energy, due to the lack of stacking between 
the two DHF ligands. The low binding energies of the DHFs (purple) in R67/D5/D5:A 
and R67/D5/D5:C are the result of weak (one hydrogen bond to K332) or limited 
interactions (hydrogen bond to only K332) with the protein. Although the DHF (purple) 
in R67/D5/D5:B does not have a hydrogen bond to the K32 residue, this DHF still has a 
medium binding energy (-8.7 kcal/mol) possibly due to the interaction with residue 168. 
This interaction is also found for other strong binding DHFs (R67/D5/D5:C, 
R67/NX/D5:A-D) and for the full ligand studies. Other insights may arise from 
calculation of the hydrogen bonds over the full trajectory instead of just from the average 
structure. However, this method was suitable for predicting the strong interactions that 
stabilize the NADPH ligand, but only provides basic conformational information for the 
flexible DHF ligand. 
5.3 Conclusion 
One measure of the inter-ligand cooperativity is given by the K&JK&\ ratio and this 
ratio varies from a low of 0.91 to a high of 15 for the single and two-site mutations. 
Previous Q67H, I67L, and Y69F quadruple mutations only observed less than 2-fold 
variation for the KMJK&I ratio upon NADPH binding.40'41 This small variation of the 
K&.IK&\ ratio was surprising since the Kd values in these quadruple mutational studies 
varied over 3 orders of magnitude. Therefore, symmetry inside the active site is important 
for a correct negative binding cooperativity for NADPH. The nonlinearity between the 
number of introduced Q67H mutations and the corresponding NADPH Kd values suggests 
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that conformational changes may be involved in binding. These changes may result from 
altered interactions between the mutant Q67H residues and the ligands or result from 
changes in ligand-ligand interactions. The Q67(H) residues are in the center of the active 
site and each Q67 residue can interact with its symmetric counterpart (Q67-Q267, 
Q167-Q367). Therefore, introduction of a Q67H mutation may alter the position of the 
other Q67(H)s.46 Such alterations led to the displacement or rearrangement of the 
nicotinamide ring of NADPH in some of the simulations. 
Also, inter-ligand interactions are crucial for the observed nonlinearity in the 
asymmetric mutations. The linear relationship between increased mutation sites and log K^ 
for binding of one NADP+ changed to a nonlinear relationship for binding of two NADPHs. 
This difference suggests that ligand-ligand interactions can cause the conformational 
changes responsible for the non-linear mutational data. 
From the simulations of mutant models, a well-overlapped interaction (i.e. 
stacking) between NADPH and Q67H is not observed for complexes involving NADPH. 
Instead, a partial stacking or parallel lineup is observed and this type of conformation is 
able to reproduce the experimental binding trends. The expected binding patterns are not 
observed for the simulations using truncated NADPH (NR) from the crystal structure 
(PDB ID: 2P4T) although overlap between the Q67H and nicotinamide is present. This 
exception may arise from the unusual anti orientation between the nicotinamide and 
ribose rings and the binding site for NADP+ may not be suitable for NR due to the 
electrostatic potential difference. Also, the overlap moves the NR ligand deeper into the 
center and may cause a loss of important interactions to the K32 residue. Therefore, even 
for a full ligand, this conformation is not likely to bind as strongly as expected. 
In contrast to the experimental results for NADPH described above, a single Q67H 
mutation has a clear effect upon the binding of DHF. Binding to the first DHF molecule 
resulted in 52-fold tighter binding, suggesting a direct interaction between the Q67H 
mutatant and the first DHF ligand. The second K^ also shows tight binding since, 
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presumably, it does not interact with the mutated residue. The two-site mutations exhibit 
different behavior, depending on the sites of the Q67H mutants. For the 
R67/DHF/DHF:A+B double mutant, both Ka values are relatively tight suggesting that 
each DHF ligand is able to stack with the Q67H and Q167H residue. For the 
R67/DHF/DHF:A+C and R67/DHF/DHF:A+D double mutants, the positive cooperativity 
between the DHF molecules is lost. The negative cooperativity caused by these two-site 
mutations suggests that the two DHFs may bind differently or lose inter-ligand 
interactions.46 
In the simulations of complexes containing DHF, the single site mutants 
R67/D5:A-D and R67/D9:A-D did not show the expected strong binding or the stacking 
between the pteridine ring and Q67H. These results suggest better models for the 
single-site mutation are required to reproduce the observed strong binding. Current models 
are taken from the full ligand studies and then the Q67H residue is introduced. Since these 
docked models are predicted for the wild type enzyme, they may not be suitable for the 
mutational studies, because the DHF may bind to the mutant with an altered conformation. 
A docking study of DHF into the mutant will be a more appropriate way to determine a 
reasonable orientation of the DHF ligand. 
In the R67/DHF/DHF:A-D mutants, the strong binding for both DHF ligands is not 
observed, but a trend does exist between the DHFs with Q67H stacking or inter-ligand 
interactions and strong binding energies, if the tail conformation has not been significantly 
altered. Also, these models can be used to predict the probable conformations of the 
two-site mutants. In R67/DHF/DHF:A+B and R67/DHF/DHF:A+D, a stacking effect 
between Q67H and the pteridine ring is possible, while significant conformational changes 




In this study, dynamics simulations have been performed on complexes involving 
truncated and full ligands as well as Q67H mutants. All simulations revealed a stable and 
conserved backbone structure across the different complexes and most binding energies 
were in agreement with the experimental trends. The positive (R67/DHF/DHF and 
R67/NADPH/DHF) and negative (R67/NADPH/NADPH) binding cooperativities were 
reproduced in the truncated and full ligands studies. In the simulations of the Q67H 
mutants, complexes involving NADPH were able to reproduce the experimental trends. 
In the mutants of R67/NADPH/DHF and R67/DHF/DHF, the increased binding energy 
for the DHF ligand was observed as expected, while the binding energy in the R67/DHF 
single-site mutations did not meet the experimental trends. Such disagreement suggests 
that the DHF orientation is important for the R67/DHF single-site mutation, as the 
expected stacking between the pteridine ring of DHF and the Q67H histidine ring was not 
observed. Such overlap is observed in the mutants of R67/NADPH/DHF and 
R67/DHF/DHF. The loss of overlap in the R67/DHF mutants demonstrates that single 
DHF is very flexible inside the active site. This is in accordance with the truncated and 
full ligand studies, where the single PTE or DHF ligand is flexible and can have altered 
binding positions. 
Although the residue contacts from the protein to the ligand may vary in different 
complexes, the most important residues involved in ligand binding match those from the 
experimental mutational studies. In the study with the truncated ligands, Q67 can fold 
down to make room for the ligand in the active site and Y69 can shift toward NR to 
create a stronger hydrogen bond. Residue Y69 appears to contribute to the negative 
cooperativity of the NR ligand. The side chains of K32, V66, and 168 and their 
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counterparts do not appear to be involved in cooperativity because overlap of the average 
structures show that these residues maintain the same conformation in each complex. All 
of the above residues, as well as residue G35 and A36, contribute the most to the binding 
energies of NADPH and DHF, as indicated by the full ligand energy decomposition study. 
Residue K32 has a significant effect on DHF binding, as loss of this contact results in a 
binding energy decrease for the DHF ligand. The interaction between the K32 residue 
and the NADPH ligand is less profound than for the DHF ligand since the energy los may 
be redirected from other residues such as Y69. In addition, the increased number of 
hydrogen bonds for the NX ligand causes it to have a higher binding energy in the 
different complexes. Also, a new NADPH tail conformation (bent toward the protein) 
was observed, which had stronger binding than the X-ray predicted position. 
Inter-ligand interactions clearly contribute the most to the positive binding 
cooperativity. In the complexes containing the truncated ligands, large numbers of 
inter-ligand contacts were found for the NR/PTE and PTE/PTE complexes. In agreement 
with the simulations, the electrostatic potential surfaces predict a preference for 
twisted-stacking to maximize the inter-ligand interactions. In the full ligand study, the 
well overlapped DHFs in R67/DHF/DHF have higher binding energies than in the 
corresponding R67/DHF complex. Although docking studies predicted a single DHF 
ligand to be in the center of the active site, simulations showed that the DHFs may adopt 
side or deep positions as well and the binding energy calculations indicated strong 
binding of DHFs in the center or deep positions. Therefore, both the center/center and 
side/deep combinations can reproduce the expected positive binding cooperativity for the 
R67/DHF/DHF complex. On the contrary, the lack of stacking observed in the 
R67/NADPH/NADPH complex is most likely due to bad steric interactions between the 
ligands and causes the negative cooperativity. 
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Fig. 35. Structures of truncated ligands (tFOL, tDHF, tDHFH+, and NR). The tDHFH+ 








Fig. 36. Backbone overlap of the X-ray crystal structure and simulated complexes 
involving truncated ligands. 
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Fig. 37. Backbone overlap of selected average structures with X-ray crystal structure. 
The same conserved backbone structure is observed for different combinations of the 
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Fig. 38. Backbone RMSDs vs. time for the simulated complexes involving full 
ligands. 
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Fig. 39. Ligand RMSD plots for the simulated complexes. For the ternary complexes, 
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